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Cardiovascular Tonic Effects of Danshen and Gegen 
Abstract 
Radix Salviae miltiorrhizae (known as Danshen) and Radix Puerariae (known 
as Gegen) have individually been used in Chinese medicine to treat coronary heart 
diseases particularly in myocardial infarction and hypertension. Therefore, the 
cardiovascular tonic effect of the compound formula of Danshen and Gegen is of 
interest to be examined. 
In "Zhong yao fang ji xian dai yan jiu da dian" (1996), Danshen, Gegen and 
Rhizoma corydalis (known as Yanhu) are formulated in the weight ratio 6:3:1 in an 
old formula. Basing on this information, preliminary investigations were carried out. 
The cardiovascular tonic effect of the compound formula of Danshen (D) to Gegen (G) 
at 7:3 ratio was further studied. For the long-term cardiovascular protection, the 
effects of the compound formula on antioxidant, vasodilation, and anti-platelet 
formation were focused. 
The antioxidant effect was investigated by 2 models, namely 
2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) induced red blood cell 
hemolysis and myocardial ischemia-reperfusion of isolated SD rat heart. IC50 of 
aqueous extract of 7:3 (D:G) compound formula in AAPH induced RBC hemolysis 
was 141 ^ig/ml. The 7:3 (D:G) compound formula protected ischemia reperfusion 
heart by exhibiting 60% contractile force recovery and reducing the heart damage 
which was reflected by heart specific enzyme LDH and CK assays. 
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The vasodilation effect was investigated by the model of isolated SD rat aorta 
rings. 7:3 (D:G) compound formula showed vasodilation in a dose dependent manner. 
The synergistic vasodilation effect of 7:3 (D:G) compound formula was shown when 
comparing with individual Danshen and Gegen. In aorta with removed endothelium 
and intact aorta treated with nitric oxide synthase inhibitor, N^-nitro-L-arginine 
(L-NNA), the vasodilation effect of Gegen extract was found to be alleviated. This 
indicates that the vasodilation effect of Gegen extract is endothelium dependent and 
the mechanism is via the function of nitric oxide synthase. 
The effect on the platelet formation was investigated by the colony forming 
unit - megakaryocyte plasma clot colony assay. The 7:3 (D:G) compound formula 
inhibited MK cell proliferation at IC50 of 161 |ig/ml. 
Capsules containing 500 mg aqueous extract of 7:3 (D:G) compound formula 
were manufactured in compliance to Good Manufacturing Practice (GMP) standard 
and double blind clinical trial with placebo was started in Prince of Wales Hospital, 
Hong Kong. 
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複方丹參葛根 (7 :3)的抗血小板形成作用利用集落形成單位巨核細胞 
(CFU-MK)血槳凝塊集落培養模式作測試。複方丹參葛根(7:3)對於巨核細胞的細 
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Chapter 1 Introduction 
Traditional Chinese Medicine (TCM) is a powerful method of healing. They are 
natural. Formulae are available in a variety of forms such as crude herbs to be boiled 
into tea, liquid bottled extracts, ground herbs packaged in pills, and powders. Herbs 
more like foods than drugs, can supplement our diet and fortify our constitution. 
They have fewer side effects when compared to Western medicine. Western 
drugs often control symptoms, but do not alter the disease process. TCM treats the 
underlying condition as defined by traditional diagnosis, and rarely causes unwanted 
side effects. Sometimes long-term use of herbs is desirable whereas extended use of 
pharmaceuticals would not be healthy. 
TCM can cure but also prevent diseases. Herbal practitioners view people as 
ecosystems in miniature and seeks to improve one's capacity to balance and renew his 
resources. Often Western medicine intervenes only after crisis arises, whereas TCM 
anticipates problems by sustaining our interior landscape. By correcting depletion and 
stagnation at earlier stages, greater problems later on are avoided. 
Sometimes Western medicine has nothing to offer for nagging chronic 
complaints that Chinese medicine can help. Western and Chinese medicines are not a 
substitute for each other and they are often complementary to each other. Whereas 
Western medicine may heroically rescue us, Chinese medicine can protect and 
preserve our health day to day. 
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This project is going to find out a cardiovascular tonic supplement from TCM. 
That supplement can gain all the advantages of TCM and at the same time overcome 
all the disadvantages such as, low potency, inconvenience and time consuming for 
taking TCM. These are some of the reasons that TCM products are not well accepted 
in Western countries. 
Radix Salviae miltiorrhizae (Danshen, in Pinyin name) and Radix Puerariae 
(Gegen, in Pinyin name) are individually studied by many research groups. Some of 
their pharmacological effects are related to cardiovascular disease treatment. 
Many research projects were done on Danshen, and a number of active 
constituents were identified, such as tanshinones I, tanshinones IIA, tanshinones IIB, 
protocatechualdhyde, salvianolic acid B and lithospermic acid. Danshen is known to 
have many pharmacological effects. It can lower blood pressure (Kang et al, 2002), 
protect ischemic reperflised myocardium (Wang et al., 1997), improve 
micro-circulation (Xue, 1986), act as anticoagulant (Onitsuka et al., 1983), act as 
antioxidant (Wu et al., 1998) and exert anti-tumor effect (Ryu et al, 1997). 
Gegen also has a number of identified active constituents, most of them are 
isoflavones or their derivatives, such as puerarin, daidzin, daidzein and genistein. 
Gegen is also known to have many pharmacological effects. It can act as a 
beta-adrenergic blocker (Feng et al., 1984), cause coronary (Fan et al., 1982) and 
cerebral vasodilatation (Tseng et al., 1974), lower blood pressure (Song et al., 1988), 
inhibit platelet aggregation (Yang et al., 1990) and exert anti-arrhythmic effect (Chai 
et al, 1985), anti-pyretic effect (Fan et al, 1997) and anti-alcoholism effect (Keung 
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and Vallee, 1998). 
Chinese herbs are usually combined in formulae to enhance their properties and 
actions. Symptoms and signs are matched with therapeutic effects, reflecting the 
particular conditions and needs of each patient. Therefore, to examine a compound 
formula of Danshen and Gegen was of interest and its cardiovascular tonic effect was 
studied. 
My studies focused on 1) working out a correct combination ratio for a better 
compound formula and 2) the effects of the formula on the cardiovascular system 
with emphasis on three major areas namely, antioxidant protection, vasodilation and 
anti-platelet formation. All this information is valuable for further study on this 
compound formula. The capsules of the compound formula were manufactured in 
compliance with Good Manufacturing Practice (GMP). The capsules were used in 
clinical trial study at Prince of Wales Hospital, Hong Kong. 
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Chapter 2 Establishment of Compound Formulation 
We are interested to produce a compound formula consisting of Danshen and 
Gegen for cardiovascular tonic use. Therefore the first step of the project was to find 
out a correct ratio to combine these two TCMs. The strategy of finding out the correct 
combination ratio of Danshen and Gegen, way that, first finding out all the existing 
compound formulae which consist of both these TCMs, and then carrying out 
preliminary experiments to identify one single chosen compound formula. 
2.1 Formulation research 
In order to find out all existing compound formulae, information in "Zhong yao 
fang ji xian dai yan jiu da dian"(Huang and Shi, 1996) was scanned. There are 34 
compound formulae being found to consist of both Danshen and Gegen. Only six of 
them are not cardiovascular tonic related. Among the 28 formulae, the most 
complicated one consists of Danshen, Gegen and 12 other TCMs, such as Ginseng, 
Sanqi, Chuanxiong. While the simplest one consists of only three TCMs, Danshen, 
Gegen and Yanhu. 
Danshen-Gegen-Yanhu tablet is the simplest formula that consists of ground 
Danshen, Gegen and Yanhu in a ratio of 6:3:1 by mass in each tablet (0.6 g). It was 
used to treat coronary heart diseases in human and the dosage was four tablets a time, 
three times a day for four weeks (孫永智，1986). Yanhu is also called Yanhusuo and 
its Latin name is Rhizoma Corydalis. Recent research shows that Yanhu has the 
pharmacological effects such as, analgesic effect (Hu et al, 1994 ； Yue, 1981), 
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hypnotic effect (Buda et al., 1984), sedative effect (Jin et al., 1984), ulceration 
protective effect (Soji et al., 1969) and muscle relaxation effect (Zhong et al, 1986). 
A series of active constituents such as ^/-corydaline, <i/-terahydropalmatine, protpine, 
corydalis L were identified too. 
With reference to the information from this tablet, the compound formula of 
Danshen to Gegen to Yanhu was in a ratio of 6:3:1. As a recent research paper shows 
that Danshen plays a very good cardioprotective role (Ji et al., 2003), one part of 
Danshen was used to replace Yanhu to form a new ratio of Danshen to Gegen in 7:3 
which was examined in our project. Ratio of Danshen to Gegen in 2:1 and 1:1 are 
more frequently found among the above mentioned 28 old compound formulae. 
Therefore, Danshen to Gegen in a ratio 2:1 and 1:1 were also tested for their possible 
cardiovascular tonic effect. 
Therefore four ratios by weights are used in my study, namely, Danshen to 
Gegen to Yanhu in 6:3:1，Danshen to Gegen in 7:3, 2:1 and 1:1. 
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2.2 Aqueous extract preparation 
The aqueous extracts of the chosen TCMs compound formulae were interesting 
because they would share more proprieties with the decoctions when compared to the 
old compound formulae. The powder form of aqueous extracts of the four focused 
compound formulae in appropriate ratios of Danshen, Gegen and Yanhu by weights 
were first prepared. And the aqueous extracts of the three individual TCMs were also 
prepared. 
2.2.1 Materials and methods 
Raw materials 
Danshen was supplied by New World China Enterprises Projects Limited and the 
Danshen was grown at Sichuan province in compliance with Good Agriculture 
Practice (GAP). Gegen and Yanhu were purchased from a local herbal company in 
Hong Kong. They were cut into small pieces before extraction, where Danshen was 
cut into pieces of size 1 x 1 x 1 cm, Gegen was cut into pieces about 3 x 3 x 0.5 cm 
pieces and Yanhu was cut into 1 x 1 x 0.5 cm pieces. 
Reflux extraction 
Appropriate amount of the raw materials were weighed and then slightly washed 
with distilled water. Raw materials were refluxed with distilled water in 1:10 (weight 
(g) to volume (ml)) for two hours on a heating mantle. The time was started to count 
after water got boiled. After two hours reflux, the decoction was left in air for an hour 
to cool down. The decoction was collected and then extra 1:10 distilled water was 
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added to the raw materials to reflux for two more hours. Similarly, decoction was 
collected after one hour of cooling. The decoction was kept in 4°C refrigerator 
overnight for further steps. 
Filtration 
Cold decoction was divided into several 450ml-centrifuge bottles and then 
centrifuged at 17,700 x g for an hour. Supernatant was collected and filtrated with 
filter paper under suction to filter out all the insoluble particles. 
Lyophilization 
Clear decoction was divided into lyophilize bottles, up to 300 ml each bottle. 
Bottles were frozen under liquid nitrogen and the frozen decoction was kept no more 
than one cm thick surrounding the inner side of the bottle. The bottles were dried on 
lyophilizer under vacuum for at least three days until dry powder appeared in the 
bottle. Powder extract was collected into falcon tubes and kept in a moisture proof 
box at room temperature. 
2.2.2 Results 
As shown in table 2.1, 98 g aqueous extract of Danshen (G), 22 g of Gegen (G), 
9 g of Yanhu (G), 109 g of 6:3:1 (D:G:Y) compound formula, 40 g of 7:3 (D:G) 
compound formula, 39 g of 2:1 (D:G) compound formula and 35 g of 1:1 (D:G) 
compound formula were yielded from 180 g, 90 g，30 g, 300 g, 100 g, 100 g and lOOg 
raw materials respectively. 
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Raw materials (g) Powder extract (g) Percentage yield (%) 
Danshen (D) 180 97.557 54.20 
Gegen (G) 90 21.645 24.05 
Yanhu (Y) 30 9.087 30.29 
6 : 3 : 1 (D:G:Y) 300 108.907 36.30 
7 ： 3 (D:G) 100 39.736 39.74 
2 : 1 (D:G) 100 39.489 39.49 
1 ： 1 (D:G) 100 34.808 34.81 
Table 2.1. The weights of raw material used and the amount of powder extract 
obtained. The percentage yield that calculated by weights shows individual Danshen 
gave the highest percentage yield while individual Gegen gave the lowest percentage 
yield. 
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2.2.3 Discussion 
The percentage yield of Danshen (D)，Gegen (G), Yanhu (Y), 6:3:1 (D:G:Y) 
compound formula, 7:3 (D:G) compound formula, 2:1 (D:G) compound formula and 
1:1 (D:G) compound formula were found to be 54.20%, 24.05%, 30.29%, 36.30%, 
39.74%, 39.49% and 34.81% respectively. The highest percentage yield was obtained 
from the extraction with Danshen while the one of Gegen was the lowest. Therefore a 
higher percentage yield was obtained from the mixture with a higher Danshen 
composition compound formula. 
The extracts of compound formulae were prepared by mixing TCMs before 
decoction but not mixing the extract of individual TCM because there may be new 
compounds formed during the step of preparation of decoction. All the compounds 
could be obtained by this mixed TCMs decoction method when compared to the 
traditional decoction of the compound formula. 
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2.3 Preliminary test 
An inhibition against 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) 
induced red blood cell hemolysis experiment was performed to compare the 
antioxidant ability of the focused compound formulae. AAPH was employed to 
produce peroxyl radicals, and erythrocyte would be lysed by lipid peroxidation. 
Therefore the antioxidant potency of the formulae could be compared by the amount 
of red blood cell lysed. 
2.3.1 Material and methods 
Animals 
300-320 g Sprague-Dawley (SD) rat was treated with ether and then blood was 
collected by tubes containing heparin at the aorta. Red blood cells were obtained by 
centrifugation and they were washed twice with 0.1 M NaCl solution. The volume of 
red blood cell was measured and 4 times volume of 0.1 M NaCl solution was added to 
obtain a 20% red blood cell suspension. 
Lysis reaction 
Seven extracts from different formulae were weighed and dissolved in PBS and 
serial dilutions were performed to obtain a series of extracts in various concentrations. 
Reactions were set up in 1.5-ml micro-centrifuge tubes, each contained a final volume 
of 1 ml of 10% red blood cell suspension, 100 mM AAPH, and extracts. Final 
concentrations of the samples were 500 |xg/ml’ 250 |ig/ml, 125 }ig/ml, 62.5 |xg/ml and 
31.25 |ig/ml. Controls were set up by using PBS instead of sample. Tubes were 
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incubated at 37°C for 200 min with oscillation. 
Determination of cell lysis 
The incubated reaction mixtures were diluted 20 fold in PBS and distilled water 
separately. They were shaken gently and then centrifuged at 1500 x g for 10 min. Two 
hundred of supernatant were transferred to flat bottom 96-well plates and the 
absorbances of them were read against 540 nm. Percentage hemolysis was the 
absorbance of the sample in PBS over absorbance of the sample in distilled water 
times 100 percentage. The percentage inhibition was the percentage hemolysis of 
control minus the percentage hemolysis of sample. The 50% inhibition concentrations 
(IC50) were used to compare the potency of the formulae. 
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2.3.2 Results 
The percentage inhibition of red blood cell hemolysis was plotted against the 
dose concentration of the seven samples, three individual TCMs and four compound 
formulae. As shown in figure 2.1, Gegen showed no antioxidant effect against AAPH 
and Yanhu showed little effect, 25% inhibition up to 1 mg/ml dosage. IC50 of Gegen 
and Yanhu could not be detected within 1 mg/ml dose range. IC50 of Danshen, 
compound formulae 6:3:1 (D:G:Y), 7:3(D:G), 2:1 (D:G) and 1:1 (D:G) were 141 
|ig/ml’ 180 ^ig/rnl, 168 |ig/ml, 198 |xg/ml and 282 |ig/ml respectively. 
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Figure 2.1. Percentage inhibition of the 3 individual formulae, Danshen (D), Gegen 
(G) and Yanhu (Y) and the 4 compound formulae, 6:3:1 (D:G:Y), 7:3 (D:G), 2:1 (D:G) 
and 1:1 (D:G). IC50 were 141 ^ig/ml, undetectable, undetectable, 180 fig/ml, 168 
jLig/ml, 198 jLig/ml and 282 jig/ml respectively, a) Curves are plotted by mean of n=7. b) 
Data are tabulated by mean 土 SD of n=7. 
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2.3.3 Discussion 
Danshen alone gave the lowest IC50 implying that Danshen was most effective 
in antioxidant activity against AAPH-induced RBC hemolysis. For the compound 
formulae, the higher the Danshen composition gave the lower IC50. Therefore the 
higher Danshen composition gave the higher antioxidant effect. The 7:3 (D:G) 
compound formula was the one showing the highest Danshen composition among the 
four formulae. 
In addition, individual Yanhu only showed a 25% inhibition up to the dose of 
1000 |J,g/ml. Its traditional application is not related to cardiovascular tonic effect but 
only to analgesic effect. However, according to the physicians views, the analgesic 
effect of Yanhu may mask the clinical observation after the extract is capsulated and 
used for clinical trial because it is dangerous if atients are suffering from 
ischemia-induced pain but the painful sign is alleviated by Yanhu. Therefore Yanhu 
was eliminated from the compound formula and the finalized target ratio is 7:3 of 
Danshen to Gegen for further studies in this thesis. 
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Chapter 3 Quality Control 
Quality of natural health products, and quality of herbal products in particular, 
has stood out as one of the most frequently cited critical issues in commercial world. 
Quality control for TCM products is not only the chemical content of the products 
itself, but also a broad regulatory perspective including authentication to avoid 
adulterants and substitutes, chemical content of the marker compounds, biological 
activity of the efficacy of product. 
Marker compounds are one or more constituents that occur naturally in the 
herbal material and that are selected for special attention by a researcher or 
manufacturer as a marker for quality control purpose (Ho and Zheng, 2002). The 
selection may be based upon a variety of different factors such as the stability of the 
constituent, technical ease of analysis, amount of time and cost of analysis, utility in 
confirming identification of the component herbals, potential relevance to therapeutic 
effect and indicator of product quality. 
The chemical content quality of the 7:3 (D:G) compound formula was 
investigated in this section by applying the high-performance liquid chromatography 
(HPLC) method. 
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3.1 HPLC standardization 
There are a number of active constituents which were identified from Danshen, 
such as the lipid-soluble compounds tanshinones I，tanshinones IIA, tanshinones IIB, 
water-soluble compounds protocatechualdehyde, salvianolic acid B and lithospermic 
acid as shown in figure 3.1. There are also a number of active constituents which were 
identified from Gegen. Most of them are isoflavones or their derivatives, such as 
puerarin, daidzin, daidzein and genistein as shown in figure 3.2. 
For the quality control purpose, Puerarin was chosen to be the marker compound 
of Gegen. Protocatechualdehyde and Salvianolic acid B were chosen to be the marker 
compounds of Danshen. 
Puerarin is the most abundant active constituent in Gegen. Formula weight of 
Puerarin is 422.3 and can be detected under UV 250nm. Protocatechualdehyde and 
Salvianolic acid B are active constituents in the aqueous fraction of Danshen. Formula 
weights of them are 138.1 and 718.0 respectively, and both of Protocatechualdehyde 
and Salvianolic acid B can be detected under UV 280nm. 
- 1 6 -
Cardiovascular Tonic Effects of Danshen and Gegen 
HO 
COOH OH 
^ C H , 0 ^ 0 - c J i 
H O O C - C H O /zCH 日 COOH 
HO 0 1 人 
A H OH 
Salvianolic acid B Protocatechualdehvde 
O O 
CH3 R1 
Tanshinone I Tanshinone II 
A: R1 = CH3 
B: R1 = CH2OH 
Figure 3.1. Structures of some active constituents of Danshen. 
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Figure 3.2. Structures of some active constituents of Gegen. Where glc represent 
glucose. 
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3.2 Materials and methods 
Chemicals 
Solvent A is HPLC grade water with 0.05% trifluoroacetic acid (TFA). Solvent B 
is HPLC grade acetonitrile with 0.05% TFA. Solvent A and B were degassed for an 
hour before use. Puerarin standard was purchased from Sigma. Protocatechualdehyde 
standard and Salvianolic acid B standard were purified and supplied by Institution of 
Chinese Medicine, The Chinese University of Hong Kong. 
HPLC conditions 
An octadecyl silica (ODS) reversed phase column (150 mm x 4.6 mm i.d.) was 
employed using a linear gradient solvent system (solvent A:B from 100:0 at 0 min to 
50:50 at 25 minutes, increasing 2% B per minute) as the mobile phase. The flow rate 
was set at 1 ml/min and the chromatogram was detected with an UV-detector at UV 
280 nm for Protocatechualdehyde and Salvianolic acids B, and 250 rnn for Puerarin. 
Sample preparation 
The extracts and standard marker compounds were dissolved in HPLC grade 
water. They were sonicated for 30 min and were passed through a 0.22 |am spore size 
filter before injecting to the HPLC system. 
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3.3 Results 
The HPLC chromatographs of standards namely, Protocatechualdehyde, 
Salvianolic acid B and Puerarin were shown in figures 3.3，3.4 and 3.5 respectively. 
Areas of 9276.77 mAUs, 13549.8 mAUs and 8153.42 mAUs were yielded by 2 |ag 
Protocatechualdehyde, 15 \ig Salvianolic acid B and 1.6 |ig Puerarin with retention 
time 9.560 min, 17.555 min and 11.872 min respectively. The ratios of the area to the 
amount of marker compounds were used for further calculations. 
The HPLC chromatograph of 100 Danshen aqueous extract was shown in 
figure 3.6. By comparing the retention time to the marker standards, the areas of 
peaks of Protocatechualdehyde and Salvianolic acid B were 537.18 mAUs and 
5365.61 mAUs respectively. Therefore, the Protocatechualdehyde and Salvianolic 
acid B contents in Danshen extract were 0.12 [ig and 5.94 ^g respectively. The HPLC 
chromatograph of 100 |ig Gegen aqueous extract was shown in figure 3.7. By 
comparing the retention time to the marker standards, the area of peak of Puerarin was 
3693.83 mAUs. Therefore, the Puerarin content in Gegen extract was 0.72 |ig. 
The HPLC chromatographs of 100 |ig 7:3 (D:G) compound formula were shown 
in figures 3.8 and 3.9. By comparing the retention time to the marker standards, the 
areas of peaks of Protocatechualdehyde, Salvianolic acid B and Puerarin were 307.99 
mAUs，5910.02 mAUs and 492.80 mAUs respectively. Therefore, the 
Protocatechualdehyde, Salvianolic acid B and Puerarin contents in 7:3 (D:G) 
compound formula were 0.07 |ig, 6.54 i^g and 0.10 \ig respectively. 
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Figure 3.3. HPLC chromatogram (280 nm) of Protocatechualdehyde standard. Ten jal 
of 0.2 mg/ml Protocatechualdehyde was injected. The peak of Protocatechualdehyde 
was shown at retention time 9.560 min. Area under the peak was calculated to be 
9276.77 mAUs. 
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Figure 3.4. HPLC chromatogram (280 nm) of Salvianolic acid B standard. Ten [d of 
0.2 mg/ml Salvianolic acid B was injected. The peak of Salvianolic acid B was shown 
at retention time 17.555 min. Area under the peak was calculated to be 13549.8 
mAUs. 
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Figure 3.5. HPLC chromatogram (250 nm) of Puerarin standard. Ten |il of 0.16 mg/ml 
puerarin was injected. The peak of Puerarin was shown at retention time 11.872 min. 
Area under the peak was calculated to be 8153.42 mAUs. 
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Figure 3.6. HPLC chromatogram (280 nm) of Danshen aqueous extract. Fifty [i\ of 2 
mg/ml Danshen aqueous extract was injected. The peak shown at retention time 9.467 
min should be Protocatechualdehyde and the area under the peak was calculated to be 
537.18 mAUs. The peak shown at retention time 17.374 min should be Salvianolic 
acid B and the area under the peak was calculated to be 5365.61 mAUs. 
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Figure 3.7. HPLC chromatogram (250 nm) of Gegen aqueous extract. Fifity ja.1 of 2 
mg/ml Gegen aqueous extract was injected. The peak shown at retention time 11.817 
min should be Puerarin and the area under the peak was calculated to be 3693.83 
mAUs. 
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Figure 3.8. HPLC chromatogram (280 nm) of 7:3 (D:G) compound formula. Fifity |il 
of 2 mg/ml 7:3 (D:G) compound formula was injected. The peak shown at retention 
time 9.569 min should be Protocatechualdehyde and the area under the peak was 
calculated to be 307.99 mAUs. The peak shown at retention time 17.463 min should 
be Salvianolic acid B and the area under the peak was calculated to be 5910.02 
mAUs. 
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Figure 3.9. HPLC chromatogram (250 nm) of 7:3 (D:G) compound formula. Fifity |il 
of 2 mg/ml 7:3 (D:G) compound formula was injected. The peak shown at retention 
time 11.864 min should be Puerarin and the area under the peak was calculated to be 
492.80 mAUs. 
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3.4 Discussion 
By applying the HPLC method, the Protocatechualdehyde, Salvianolic acid B 
and Puerarin contents in 7:3 (D:G) compound formula were 0.07% , 6.54% and 
0.10% by weight respectively. These data are useful for monitoring the batch to batch 
quality of the formula production. The contents of marker compounds are also useful 
in determination of the formula stability during the long-term storage. 
Among the findings in this section, the portion of the marker compounds yielded 
in 7:3 (D:G) compound formula were different from the individual Danshen and 
Gegen extract. Salvianolic acid B content in Danshen extract is 5.94% while the 
content is 6.54% in 7:3 (D:G) compound formula. The compound formula consisted 
of 70% Danshen portion but yielded a higher percentage content of salvianolic acid B. 
Therefore, Gegen may enhance the salvianolic acid B extraction efficiency by an 
unknown mechanism. It may explain the philosophy of TCM used in compound 
formula in a scientific point of view. As in Chinese medicine, the TCMs are always 
combined in appropriate ratio for decoction. And some TCMs are always used 
together to enhance one another or to neutralize one another in terms of synergistic 
effect. 
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Chapter 4 Antioxidant study 
For long-term prevention of cardiovascular disease, decreasing the oxidative 
stress of the blood stream by antioxidant agents is effective. Attack with reactive 
radicals on membranes or lipoproteins starts lipid peroxidation, which is particularly 
implicated in the development of atherosclerosis (Halliwell, 1997). Atherosclerosis is 
one of the major chronic cardiovascular diseases. Atherosclerosis will narrow down 
the cross section area of the vessels, forming foams fatty streak first, and then fibrous 
plaque and finally becoming complicated lesion. The formation of atherosclerosis is 
related to the oxidative stress of the blood stream. Low density lipoprotein (LDL) is 
first oxidized by free radicals at the intima and they are then aggregated together. 
After that, they cause damage to the endothelium (Cochrane, 1991) and turn on the 
immune system. More macrophages will migrate to the site and inflammation occurrs. 
The scavenger receptors on the surface of macrophages and smooth muscle will 
interact with oxidized LDL to induce the formation of foam cells (Suematsu et al., 
1993 ； Ward, 1991). Foam cells cannot be easily removed and they are continuously 
accumulating with lipids and calcium to narrow down the vessels. 
Two models were applied to investigate the antioxidant effect of the 7:3 (D:G) 
compound formula. The two models are AAPH induced red blood cell hemolysis and 
ischemia reperftision of isolated rat heart on Langendorff apparatus. 
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4.1 Red blood cell hemolysis model 
An inhibition of 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), 
induced red blood cell hemolysis experiment has been performed to examine the 
antioxidant ability of the compound formula at 7:3 (D:G). 
4.1.1 Materials and Methods 
Same as described in section 2.3.1. 
4.1.2 Results 
Sharing the results obtained in section 2.3.2, the data on the percentage inhibition 
of red blood cell hemolysis were re-plotted against the dose concentration of the three 
samples, Danshen (D) and Gegen (G) alone, and the 7:3 (D:G) compound formula as 
shown in figure 4.1. Gegen showed no antioxidant effect against AAPH. IC50 of 
Gegen could not be detected within 1 mg/ml dose range. IC50 of Danshen and 
compound formula 7:3 (D:G) were found to be 141 |ig/ml and 168 |ig/ml respectively. 
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Figure 4.1. Percentage inhibition of AAPH induced hemolysis of the individual 
Danshen (D) and Gegen (G)，and the 7:3 (D:G) compound formula. IC50 were 141 
|ig/ml, undectectable and 168 ^ig/ml respectively. Data are represented by mean 土 SD 
ofn=7. 
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4.1.3 Discussion 
Percentage hemolysis was the absorbance of the sample in PBS over absorbance 
of the sample in distilled water times 100 percentage. The percentage inhibition was 
the percentage hemolysis of control minus the percentage hemolysis of sample. The 
50% inhibition concentrations (IC50) were used to compare the potency of the 
formulae. Therefore the lower the IC50 value the higher the potency of the sample to 
counteract the AAPH induced red blood cell hemolysis. Danshen was more potent 
than the 7:3 (D:G) compound formula, as the IC50 of Danshen was 141 |j,g/ml while 
7:3 (D:G) compound formula is 168 |ag/ml. Although Gegen did not show positive 
protective effects, at least, with unknown mechanism, the protective effect of 7:3 
(D:G) compound formula did not show a sudden drop in the presence of Gegen. 
Gegen did not show positive protection as an antioxidant did. However, it may play 
other role that affects other systems in the body to supplement the cardiovascular 
tonic actions. 
The formation of atherosclerosis is related to the oxidative stress of the blood 
stream, e.g. decrease the chance of forming oxidizing LDL. Atherosclerosis may be 
prevented by daily supplement of 7:3 (D:G) compound formula as it can quench the 
oxidants. For the patients who are suffering atherosclerosis, 7:3 (D:G) compound 
formula may help as secondary prevention because the daily supplement of 7:3 (D:G) 
compound formula may maintain a high level of antioxidant that slows down the 
chance of atherosclerosis formation. 
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4.2 Ischemia-reperfusion on Langendroff 
Ischemia is a situation that the oxygen supply is decreased that causes 
insufficient oxygen to carry out normal metabolism (Hearse, 1994). After ischemia, 
the restoration of oxygen supply is called reperfusion. Reperfiision restores the 
oxygen content but it will cause injury to the organ. It was because the level of 
hypoxanthine will be increased when ischemia occurs (Manning et al., 1988). 
Hypoxanthine converses xanthine dehydrogenase into xanthine oxidase during 
ischemia (McCord et al., 1985). Once the oxygen content is restored, the xanthine 
oxidase will turn oxygen into free radicals which damage cells and cause the 
ischemia-reperfusion injury. 
To examine the effect of the extracts on the ischemia-reperfusion injury, an 
isolated rat heart was cannulated on a Langendorff apparatus and an ex-vivo 
ischemia-reperfusion injury assay was performed. Extracts of compound formula 
were added before reperfusion in order to investigate the protective effects against the 
ischemia-reperfusion injury. Four parameters were monitored to compare the heart 
function. The four parameters are heart contractile force, coronary flow rate, and the 
heart specific enzyme activities, namely, lactate dehydrogenase and creatine kinase 
activities. 
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4.2.1 Materials and Methods 
Chemicals 
Heparin sodium salt from porcine intestinal mucosa, creatine kinase diagnostic 
kit and lactate dehydrogenase diagnostic kit were purchased from Sigma. Krebs 
solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgSCU, 1.2 mM KH2PO4, 5.55 
mM D-glucose, 25.0 mM NaHCOs and 2.5 mM CaCb) was adjusted to pH 7.4 and 
filtered. 
Animals 
220-250 g male Sprague-Dawley (SD) rat was killed by cervical dislocation. The 
chest was opened and the heart was excised within one minute. The excised heart was 
immediately put into cold heparinized Krebs solution with 50 unit/ml heparin to 
prevent blood clotting. The surrounding connective tissues and fats were quickly 
removed and therefore a single opening aorta was recognized. The excised heart was 
cannulated on a Langendroff apparatus. 
Ischemia-Reperfusion on Langendorff apparatus 
The aorta of rat heart was cannulated on the Langendorff apparatus and held 
tightly by a wire. Thirty-seven °C pre-warmed and 95% oxygen with 5% carbon 
dioxide gassed Krebs solution was allowed to perfuse into the heart. A basal level 
force was applied to the rat heart to induce its contraction. The force was increased up 
to 2 g at the increasing rate less than 0.5 g per minute. The rat heart was left for 20 
minutes for equilibration. The supply of Krebs solution was stopped and started 
ischemia for 29 minutes. Two hundred |xl of sample was injected to the reservoir 
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before a 15-minute length reperfusion. Krebs solution was used instead of the sample 
for the control set. Measurements with 17 time points were made at 10 min and 20 
min during the equilibration period, and every minute during the 15-minute 
reperfusion period. 
Contractile force measurement 
The contractile force was determined by a wire which was connected to a force-
displacement transducer. The force displacement transducer was connected to a 
Polygraph to plot out the contractile force. The percentage contractile force recovery 
was the contractile force during reperfusion compared to the average values at 
minute and minute equilibration period of the same rat. 
Coronary flow rate measurement 
Amount of the coronary heart filtrate was collected and measured for one minute. 
By making an assumption that density of the heart filtrate is 1 g/ml, same as water, the 
weight of the heart filtrate collected within the particular one minute is the average 
flow rate in the units of ml/min. The percentage coronary flow rate recovery was the 
coronary flow rate during reperfusion compared to the average values at 10th minute 
and 20th minute of equilibration of the same rat. 
Lactate dehydrogenase activity measurement 
Fifity III of the heart filtrate was added to a pre-wanned 30°C cuvette containing 
1 ml lactate dehydrogenase reagent and mixed by inversion. After 30 seconds 
incubation, the absorbance was read at wavelength 340 nm versus water as reference. 
Absorbances were read at 30-second intervals for a period of 60 seconds. The activity 
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of lactate dehydrogenase in the unit of U/L is the change of absorbance per minute 
(A A/min) times 3376. 
Creatine kinase activity measurement 
Twenty of the heart filtrate was added to a pre-wanned 30°C cuvette 
containing 1 ml creatine kinase reagent and mixed by inversion. After three minutes 
incubation, the absorbance was read at wavelength 340 nm versus water as reference. 
Absorbances were read at 30-second intervals for a period of 120 seconds. The 
activity of creatine kinase in the unit of U/L is the change of absorbance per minute 
(AA/min) times 8200. 
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4.2.2 Results 
Dose responses on ischemia-reperfusion protection of the three samples, 7:3 
(D:G) compound formulae, individual Danshen (D) and Gegen (G), were investigated. 
Five concentrations, 1 mg/ml, 2 mg/ml, 4 mg/ml, 8mg/ml and 16 mg/ml, of the three 
samples were examined. 
a) 7:3 (D:G) compound formula 
Protective effect of 7:3 (D:G) compound formula was demonstrated at contractile 
force recovery during reperfusion. As shown in figure 4.2，dose from 1 mg/ml to 4 
mg/ml showed a small protection at around 30% recovery when compared to the 
control at about 20% recovery. Obvious protection was shown when the dose 
increased to 8 mg/ml, where the recovery was around 60%. But the protective effect 
was reduced when the dose was increased up to 16 mg/ml, where the recovery 
dropped to 30%. 
Protective effect of 7:3 (D:G) compound formula was also demonstrated at 
coronary flow rate recovery during reperfusion when the dose is 2 mg/ml or higher. 
As shown in figure 4.3，dose of 1 mg/ml did not show protection at around 40% 
recovery, as the same as the control. Dose of 2 mg/ml showed around 60% recovery 
and dose of 4 mg/ml showed around 80% recovery. Obvious protection was shown 
when the dose was increased to 8 mg/ml, where the recovery was over 100% at some 
time points. But the protective effect was reduced when the dose was increased up to 
16 mg/ml, where the flow rate recovery dropped to around 65%. 
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Protective effect of 7:3 (D:G) compound formula was demonstrated at 
accumulating leakage of lactate dehydrogenase during reperfusion when the dose 
between 2 mg/ml to 8 mg/ml were used. As shown in figure 4.4，dose of 1 mg/ml did 
not show protection that 4.8 U of lactate dehydrogenase which was similar to the 
control of 4.5 U. When the dose was increased from 2 mg/ml to 8 mg/ml, the amount 
of lactate dehydrogenase was reduced from 3.9 U to 3.3 U. But the protection effect 
was reduced when the dose was increased up to 16 mg/ml, where the amount of 
lactate dehydrogenase was 5.3 U. 
Protective effect of 7:3 (D:G) compound formula was demonstrated at 
accumulating leakage of creatine kinase during reperfusion when the dose between 2 
mg/ml to 8 mg/ml were used. As shown in figure 4.5，dose of 1 mg/ml did not show 
protection that 13.6 U of creatine kinase was leaked out, similar to the control of 13.6 
U. When the dose was increased from 2 mg/ml to 4 mg/ml, the amount of creatine 
kinase was reduced from 11.9 U to 10.7 U. Obvious protection was shown when the 
dose was increased to 8 mg/ml, where the amount of creatine kinase dropped to 6.2 U. 
But the protection effect was reduced when the dose was increased up to 16 mg/ml, 
where the amount of creatine kinase was 16.0 U that was much more than the control. 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 5 5 % ± 1 8 % 5 4 % ± 1 5 % 6 3 % ± 1 % 8 0 % ± 3 3 % 8 9 % ± 7 % 6 2 % ± 2 7 % 
2 4 4 % ± 1 7 % 4 2 % 土 1 2 % 4 0 % ± 8 % 5 8 % ± 6 % 6 9 % ± 2 7 % 5 0 % ± 1 8 % 
3 3 0 % ± 1 1 % 2 7 % 土 5 % 2 8 % 土 1 0 % 4 5 % ± 1 0 % 6 1 % ± 2 4 % 3 8 % ± 2 5 % 
4 2 2 % 土 8 % 1 9 % ± 1 0 % 2 8 % ± 9 % 4 0 % 土 9 % 5 7 % 土 2 1 % 3 0 % ± 1 9 % 
5 2 1 % ± 7 % 2 1 % ± 1 1 % 2 8 % ± 7 % 3 6 % ± 1 3 % 5 4 % ± 1 9 % 3 1 % ± 2 0 % 
6 2 1 % ± 6 % 2 2 % ± 1 0 % 3 0 % ± 4 % 3 6 % 土 5 % 5 4 % ± 2 0 % 3 0 % ± 2 0 % 
7 2 1 % ± 6 % 2 4 % ± 8 % 3 0 % ± 5 % 3 6 % ± 4 % 5 3 % ± 1 6 % 3 1 % ± 2 2 % 
8 2 2 % ± 5 % 2 6 % 土 6 % 3 1 % ± 6 % 3 6 % 土 8 % 5 4 % ± 1 6 % 2 9 % ± 2 2 % 
9 2 2 % ± 6 % 2 7 % ± 4 % 3 0 % ± 5 % 3 6 % ± 7 % 5 6 % ± 1 6 % 2 9 % ± 2 2 % 
10 2 2 % 土 6 % 2 7 % ± 5 % 3 0 % ± 7 % 3 7 % ± 9 % 5 8 % ± 1 6 % 3 0 % ± 2 1 % 
11 2 2 % 土 6 % 2 8 % ± 4 % 3 1 % 士 8 % 3 7 % ± 9 % 5 9 % ± 1 7 % 3 0 % 土 2 1 % 
12 2 2 % ± 6 % 2 9 % 土 5 % 3 5 % 士 8 % 3 9 % ± 5 % 6 1 % ± 1 8 % 3 0 % ± 2 1 % 
13 2 3 % ± 6 % 2 9 % ± 4 % 3 3 % ± 8 % 4 0 % ± 6 % 6 3 % ± 1 9 % 3 0 % ± 2 1 % 
14 2 2 % ± 9 % 3 0 % ± 4 % 3 3 % ± 5 % 4 0 % ± 9 % 6 5 % ± 1 8 % 3 1 % ± 2 1 % 
15 2 3 % ± 1 0 % 3 0 % ± 5 % 3 5 % ± 1 0 % 4 1 % ± 8 % 6 6 % ± 1 8 % 3 0 % ± 2 2 % 
Figure 4.2. Contractile force recovery of ischemia-reperfusion injured heart protected 
by 7:3 (D:G) compound formula at various doses, a) Curves were plotted by the mean 
of 3 rat hearts per group, b) Data are tabulated by mean ± SD of 3 rat hearts for each 
group. 
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1^100% - 产 ^ * *——* 
I y 
I 40% - • 蠢 ^ I - ^ C o n t r o l 
o - » - 1 mg/ml 
^ 2 mg/ml 
20% - - * - 4 m g / m l 
—*— 8 m^ml 
0% . , , , , , , I , , . " • • 1 6 mg/ml 
1 2 3 4 5 6 7t . 8, . � 9 10 11 12 13 14 15 
Time (mm) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 3 2 % ± 8 % 3 3 % ± 7 % 4 0 % ± 1 2 % 4 3 % ± 1 1 % 5 3 % ± 2 7 % 4 8 % ± 2 7 % 
2 4 1 % 土 8 % 3 6 % ± 4 % 5 0 % ± 1 2 % 5 6 % ± 0 % 6 7 % ± 2 5 % 5 6 % ± 2 0 % 
3 4 2 % ± 8 % 3 9 % ± 5 % 5 8 % ± 1 2 % 6 8 % ± 5 % 8 4 % ± 2 3 % 6 8 % ± 3 5 % 
4 4 2 % ± 8 % 4 1 % ± 6 % 5 9 % ± 1 5 % 7 6 % ± 7 % 1 0 2 % ± 2 1 % 6 7 % ± 3 4 % 
5 4 4 % ± 8 % 4 2 % 土 5 % 6 1 % ± 1 3 % 7 8 % ± 9 % 1 0 5 % ± 2 7 % 6 8 % ± 3 5 %  
~ 6 4 8 % ± 8 % 4 4 % ± 7 % ~ 6 6 % ± 1 3 % 7 8 % ± 9 % 1 1 2 % ± 3 2 % 7 1 % ± 3 4 % 
7 4 9 % ± 8 % 4 6 % 土 8 % 6 0 % ± 1 0 % 8 0 % ± 9 % 1 1 6 % ± 3 0 % 6 9 % ± 3 5 % 
8 5 0 % ± 8 % 4 6 % 土 8 % 6 5 % ± 1 2 % 8 0 % ± 1 1 % 1 1 8 % ± 3 2 % 7 1 % 土 3 2 % 
9 5 1 % ± 8 % 4 7 % ± 8 % 7 0 % ± 1 0 % 8 2 % ± 1 4 % 1 1 2 % ± 2 8 % 7 3 % ± 3 0 % 
10 5 2 % ± 8 % 4 8 % ± 9 % 6 1 % ± 1 0 % 7 9 % ± 1 1 % 1 1 2 % 土 2 6 % 6 6 % 土 3 2 % 
11 5 2 % ± 8 % 4 9 % ± 1 0 % 61% ± 9 % 8 0 % ± 1 4 % 1 1 1 % ± 2 5 % 6 6 % ± 2 9 % 
12 5 3 % ± 8 % 5 0 % ± 1 0 % 6 3 % ± 9 % 8 0 % ± 1 6 % 1 0 8 % ± 2 2 % 6 3 % ± 3 0 % 
13 5 3 % ± 8 % 5 0 % ± 1 1 % 5 9 % ± 8 % 8 0 % ± 1 4 % 1 0 7 % ± 2 0 % 6 4 % ± 2 8 % 
14 5 4 % ± 8 % 5 1 % ± 1 2 % 6 4 % ± 1 0 % 7 9 % ± 1 4 % 1 0 1 % ± 2 0 % 6 4 % ± 2 6 % 
15 5 3 % ± 8 % 5 2 % ± 1 3 % 6 4 % ± 1 3 % 8 2 % ± 1 3 % 1 0 2 % ± 1 6 % 6 2 % ± 2 4 % 
Figure 4.3. Coronary flow rate recovery of ischemia-reperfusion injured heart 
protected by 7:3 (D:G) compound formula at various doses, a) Curves were plotted by 
the mean of 3 rat hearts per group, b) Data are tabulated by mean ± SD of 3 rat hearts 
for each group. 
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0 I 1 1 1 1 1 1 1 1 1 1 1 1 1 I  
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 
Time (min) 
b) 
Accumulating leakage ofLDH (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0.26 土 0.12 0.22土 0.05 0.25 土 0.06 0.31 土 0.09 0.23 土 0.09 0.19 土 0.09 
2 0.44 ± 0.13 0.37± 0.06 0.43± 0.08 0.49 ± 0.12 0.37± 0.11 0.37± 0.14 
3 0.65土 0.14 0.58土 0.10 0.68 土 0.10 0.74土 0.18 0.55土 0.15 0.67 士 0.21 
4 0 . 9 3 土 0 . 1 6 0 . 87 土 0 . 1 7 0 . 9 5 ± 0 . 12 1 .08土 0 . 20 0 . 7 8 土 0 . 18 1 . 0 2 ± 0 . 22 
5 1.24土 0.18 U8土 0.25 1.25土 0.14 1.30土 0.23 1.01 土 0.20 1.43土 0.27 
6 1.58 土 0.21 1.52土 0.35 1.49土 0.18 1.57土 0.28 1.29 土 0.26 1.88土 0.31 
7 1 . 94土 0 . 23 1 .90土 0 . 47 1 . 7 6 ± 0 . 20 1.81 土 0 . 32 1 .53土 0 . 25 2 . 35土 0 . 39 
8 2.29 土 0.28 2.26 土 0.56 2.07 土 0.22 2.06 土 0.37 1.78 土 0.25 2.85 土 0.49 
9 2 . 64 土 0 . 35 2 .63 ± 0 . 68 2 .37 士 0 . 25 2 .27 ± 0 . 42 1.99 ± 0 .25 3.31 ± 0 . 59 
10 3 . 0 0 土 0 . 4 3 3 .01 土 0 . 7 8 2 . 68 土 0 . 2 7 2 . 54 士 0 . 4 6 2 .21 土 0 . 2 7 3 . 68 土 0 . 6 4  
~ T \ 3 . 3 2 ± 0 . 5 3 3 . 3 8 ± 0 . 8 7 2 . 9 5 ± 0 . 3 1 2 . 7 6 ± 0 . 5 1 2 . 4 9 ± 0.34 4.06 ± 0.69 
12 3 . 6 5 土 0 . 6 3 3 . 7 6 土 0 . 95 3 .21 土 0 . 35 2 . 98 ± 0 . 54 2 . 74 土 0 . 4 0 4 . 4 4 土 0 . 68 
13 3 . 98 土 0 . 6 9 4 . 1 2 土 1.01 3 . 46 ± 0 . 3 6 3 .23 土 0 . 52 1 9 4 土 0 . 37 4 . 77 土 0 . 67 
14 4 . 2 7 土 0 . 7 7 4 . 4 7 土 1 .08 3 .73 土 0 . 3 9 3 .44 士 0 . 52 3 .11 土 0 . 38 5 .09 土 0 . 65 
15 4.55土 0.80 4.80 士 1.15 3.98土 0.43 3.64 土 0.56 3.32土 0.43 5.35土 0.69 
Figure 4.4. Accumulating leakage of lactate dehydrogenase of ischemia-reperfusion 
injured heart protected by 7:3 (D:G) compound formula at various doses, a) Curves 
were plotted by the mean of 3 rat hearts per group, b) Data are tabulated by mean 土 
SD of 3 rat hearts for each group. 
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a) 
18 
1 1 : 卜 Control ^ ^ ^ ^ ^ ^ ^ 
S 8 - " • - 1 mg/ml 
Q ,.• i j „.„„....i.. 』 j ...i ； i , i ； 
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 
Time (min) 
b) 
Accumulating leakage of CK (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0.54土 0.29 0.26土 0.07 0.32土 0.05 0.13土 0.05 0.13土 0.05 0.11 土 0.04 
2 0 . 9 2 土 0 . 3 4 0 . 4 8 土 0 . 09 0 . 64 土 0 . 1 0 0 . 45土 0 . 04 0 . 3 4 ± 0 . 09 0 . 2 8 土 0 . 1 2 
3 1 .49士 0 . 3 7 0 . 89 土 0 . 1 4 1 .19士 0 . 15 0 . 85土 0 . 08 0 .61 土 0 . 1 6 0 . 77士 0 . 15 
4 2 . 2 3 土 0 . 4 3 1.58 土 0 . 3 6 1.93 土 0 . 25 1.53 土 0 .41 1.05 土 0 . 2 6 1.62 ± 0 .23 
5 3.12± 0.56 2.42± 0.60 2.87 ± 0.50 2.45± 1.04 1.47 ± 0.37 2.77± 0.64  
~ 6 4.13 ± 0 . 7 4 3 . 4 2 ± 0 . 9 7 3 . 8 4 ± 0 . 8 2 3 . 6 5 ± 1 . 8 2 2 . 0 0 ± 0 . 4 3 4 . 2 0 ± 1.21 
7 5 . 20土 0 . 9 7 4 . 4 4 土 1.28 4 . 87土 1 .24 4 . 7 5 ± 2.61 2 .41 土 0 . 60 5 . 65土 1 .88 
8 6.30 土 1.23 5.61 土 1.69 6.10士 1.70 5.76 土 3.16 2.91 土 0.73 7.25土 2.66 
9 7.42土 1.54 6.80土 2.05 7.06土 2.14 6.65士 3.64 3.35土 0.89 8.83± 3.38 
10 8 . 56土 1.91 7 .91 土 1 3 2 7 . 98土 2 .43 7 . 37土 4 .01 3 . 7 8 ± 1.02 10.11 土 3 .83  
~ n 9.68± 2 . 3 7 9 . 1 5 ± 2 . 6 8 8 . 8 4 ± 2 . 7 2 8 . 1 0 土 4 . 3 5 4 . 1 9 土 1 . 1 5 1 1 . 4 8 ± 4.28 
12 1 0 . 7 5 ± 2 . 74 10 .32士 2 . 89 9 .61 土 2 . 89 8 . 72土 4 . 7 3 4 . 7 2 土 1.21 12 .68士 4 . 5 7 
13 11.74 土 3.08 11.46土 3.17 10.37土 3.14 9.41 土 5.01 5.22 土 1.36 13.88土 4.91 
14 12 .74土 3 . 42 1 2 . 5 2 ± 3 .38 11 .08土 3 .33 10 .09土 5 . 22 5 . 7 0 ± 1.43 1 5 . 0 0 ± 5 .23 
15 13.61 土 3.70 13.59士 3.60 11.86 土 3.50 10.69 土 5.51 6.17土 1.57 16.06土 5.42 
Figure 4.5. Accumulating leakage of creatine kinase of ischemia-reperfusion injured 
heart protected by 7:3 (D:G) compound formula at various dose, a) Curves were 
plotted by the mean of 3 rat hearts per group, b) Data are tabulated by mean 土 SD of 3 
rat hearts for each group. 
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b) Danshen 
Protective effect of Danshen was demonstrated at contractile force recovery 
during reperfusion. As shown in figure 4.6, the contractile force recovery of control 
was around 20%. Danshen exhibited protection to the ischemia-reperfusion injury 
when the dose was increased from 1 mg/ml to 8 mg/ml, the contractile fore recovery 
was enhanced from around 30% to around 60 %. But the protectiive effect was 
reduced when the dose was increased up to 16 mg/ml, where the recovery dropped to 
remain around 10% 
Protective effect of Danshen was demonstrated at coronary flow rate recovery 
during reperfusion when the dose is 2 mg/ml or higher. As show in figure 4.7，dose of 
1 mg/ml did not show protection at around 40% to 50% recovery as the same as the 
control. Dose of 2 mg/ml showed around 80% recovery and dose of 4 mg/ml showed 
around 100% recovery. Obvious increased flow rate was shown when the dose was 
increased to 8 mg/ml, where the recovery was increased over 100% and reached 
140%. But the protection effect was reduced when the dose was increased up to 16 
mg/ml, where the flow rate recovery dropped to around 60%. 
Protective effect of Danshen was demonstrated at accumulating leakage of 
lactate dehydrogenase during reperfusion when the dose between 4 mg/ml to 8 mg/ml 
were used. As shown in the figure 4.8，dose of 1 mg/ml and 2 mg/ml did not show 
much protection that 4.2 U and 3.9 U of lactate dehydrogenase respectively, which 
were slightly lower than the control of 4.5 U. When the dose was increased from 4 
mg/ml to 8 mg/ml, the amount of lactate dehydrogenase was obviously dropped to 2.8 
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U and 2.2 U. But the protection effect was reduced when the dose was increased up to 
16 mg/ml, where the amount of lactate dehydrogenase was 7.1 U that was much more 
than the control. 
Protective effect of Danshen was demonstrated at accumulating leakage of 
creatine kinase during reperfusion when the dose between 1 mg/ml to 8 mg/ml were 
used. As shown in figure 4.9, dose of 1 mg/ml showed slightly protection that 12.4 U 
of creatine kinase was leaked when comparing to the control of 13.6 U. When the 
dose was increased from 2 mg/ml to 4 mg/ml, the amount of creatine kinase was 
reduced from 10.6 U to 9.8 U. Obvious protection was shown when the dose was 
increased to 8 mg/ml, where the amount of creatine kinase dropped to 4.1 U. But the 
protection effect was reduced when the dose was increased up to 16 mg/ml, where the 
amount of creatine kinase was 25.3 U that was much more than the control. 
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a) 
90% 
V • Control 
80% - 1 mg/ml 
-it—2 m^ml 
20% - • • • • • • • 
10% - •—— — • — • 
0% 1 1 1 1 1 1 1 1 1 1 1 1 1 I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 5 5 % ± 1 8 % 5 8 % ± 1 9 % 6 5 % ± 2 9 % 8 5 % ± 1 6 % 7 5 % ± 1 9 % 5 2 % ± 2 0 % 
2 4 4 % ± 1 7 % 4 4 % ± 2 4 % 6 1 % ± 3 4 % 7 6 % ± 3 0 % 7 3 % ± 2 2 % 2 9 % ± 1 2 % 
3 3 0 % ± 1 1 % 2 5 % ± 1 3 % 5 6 % ± 3 6 % 6 1 % ± 2 9 % 7 3 % ± 2 0 % 1 8 % ± 8 % 
4 2 2 % ± 8 % 2 4 % ± 1 0 % 4 9 % ± 3 5 % 6 2 % 土 3 1 % 7 1 % 土 1 7 % 1 6 % ± 5 % 
5 2 1 % ± 7 % 2 6 % ± 8 % 4 5 % ± 3 1 % 4 7 % ± 2 0 % 6 8 % ± 1 0 % 1 3 % 土 9 %  
~ ~ 6 2 1 % ± 6 % 2 6 % ± 7 % 4 1 % ± 2 8 % 4 6 % ± 1 9 % 5 1 % ± 2 6 % 1 2 % ± 8 % 
7 2 1 % ± 6 % 2 6 % ± 7 % 3 9 % ± 2 4 % 4 7 % ± 2 0 % 5 1 % ± 2 5 % 9 % ± 5 % 
8 2 2 % ± 5 % 2 6 % ± 7 % 3 9 % ± 2 3 % 4 8 % ± 2 1 % 5 2 % ± 2 7 % 1 0 % ± 5 % 
9 2 2 % ± 6 % 2 7 % 土 8 % 3 9 % ± 2 4 % 5 0 % ± 2 2 % 5 4 % ± 2 9 % 1 0 % 土 4 % 
10 2 2 % ± 6 % 2 7 % 土 8 % 4 0 % ± 2 4 % 5 5 % 土 2 1 % 5 5 % ± 3 0 % 9 % ± 8 % 
11 2 2 % ± 6 % 2 8 % ± 9 % 4 0 % ± 2 5 % 5 4 % 士 2 5 % 5 6 % 土 3 1 % 1 0 % ± 6 % 
12 2 2 % ± 6 % 2 8 % ± 8 % 4 1 % ± 2 4 % 5 6 % ± 2 6 % 6 3 % ± 2 4 % 1 0 % 土 6 % 
13 2 3 % ± 6 % 2 8 % ± 9 % 4 1 % ± 2 5 % 5 6 % ± 2 7 % 6 6 % ± 2 7 % 1 2 % ± 7 % 
14 2 2 % ± 9 % 2 8 % 土 8 % 4 2 % ± 2 5 % 5 7 % ± 2 8 % 7 2 % ± 2 1 % 1 2 % ± 4 % 
15 2 3 % 土 1 0 % 2 9 % ± 1 0 % 4 1 % ± 2 6 % 5 8 % ± 2 9 % 6 8 % ± 2 9 % 1 2 % ± 6 % 
Figure 4.6. Contractile force recovery of ischemia-reperfusion injured heart protected 
by Danshen at various doses, a) Curves were plotted by the mean of 3 rat hearts per 
group, b) Data are tabulated by mean 土 SD of 3 rat hearts for each group. 
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a) 
160% • ~ ^  
• Control 
140% - - 1 mg/ml * 
0 - • - 1 6 mg/ml 
1 4 0 % ^ ^ , • ^ ^ 
20% 
0% 1 1 1 1 1 1 1 1 1 1 1 1 I I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 3 2 % ± 8 % 3 7 % ± 1 7 % 4 6 % ± 6 % 5 4 % ± 1 8 % 5 0 % ± 2 7 % 4 9 % ± 1 7 % 
2 4 1 % ± 1 2 % 4 3 % ± 2 3 % 5 4 % ± 8 % 5 7 % ± 1 4 % 6 2 % ± 2 3 % 5 5 % ± 2 3 % 
3 4 2 % ± 1 5 % 4 4 % ± 2 2 % 6 5 % ± 2 1 % 7 0 % ± 2 5 % 8 5 % ± 2 5 % 6 1 % ± 2 2 % 
4 4 2 % ± 1 8 % 4 5 % 土 2 3 % 7 6 % ± 3 5 % 8 2 % ± 2 7 % 1 0 1 % ± 4 6 % 6 2 % ± 2 0 % 
5 4 4 % ± 1 8 % 4 7 % ± 2 8 % 8 8 % ± 4 3 % 8 6 % 士 2 6 % 1 1 1 % ± 3 9 % 6 0 % ± 1 8 % 
6 4 8 % ± 1 9 % 4 8 % ± 2 8 % 8 8 % 土 4 9 % 9 6 % ± 3 1 % 1 2 3 % 土 2 7 % 6 4 % ± 2 0 % 
7 4 9 % ± 1 6 % 5 4 % ± 2 4 % 8 5 % ± 4 8 % 9 7 % ± 2 9 % 1 3 4 % ± 1 5 % 6 6 % ± 2 4 % 
8 5 0 % ± 1 6 % 5 3 % ± 2 4 % 8 3 % ± 4 2 % 9 8 % ± 3 2 % 1 3 8 % ± 1 7 % 5 9 % 土 2 4 % 
9 5 1 % ± 1 6 % 5 4 % ± 2 5 % 8 1 % ± 3 8 % 9 2 % ± 2 7 % 1 4 2 % ± 4 % 6 2 % ± 2 3 % 
10 5 2 % ± 1 6 % 5 5 % ± 2 4 % 7 9 % ± 3 5 % 9 6 % ± 2 2 % 1 4 4 % ± 5 % 6 4 % ± 2 3 % 
11 5 2 % 土 1 6 % 5 8 % ± 2 6 % 7 8 % 土 3 5 % 9 4 % 土 2 2 % 1 4 2 % ± 4 % 6 1 % 土 2 4 % 
12 5 3 % ± 1 7 % 5 5 % ± 2 6 % 7 6 % ± 3 1 % 8 8 % ± 2 9 % 1 4 9 % ± 2 % 6 3 % ± 2 1 % 
13 5 3 % ± 1 7 % 5 3 % ± 3 1 % 7 9 % ± 3 5 % 8 9 % ± 2 3 % 1 3 9 % ± 6 % 6 1 % ± 2 6 % 
14 5 4 % ± 1 7 % 5 3 % ± 2 9 % 7 2 % ± 2 4 % 8 6 % ± 2 2 % 1 4 7 % ± 1 4 % 6 5 % ± 2 6 % 
15 5 3 % ± 1 7 % 5 2 % ± 3 0 % 7 1 % 土 2 3 % 8 5 % ± 2 0 % 1 3 1 % ± 1 6 % 6 2 % ± 2 4 % 
Figure 4.7. Coronary flow rate recovery of ischemia-reperfusion injured heart 
protected by Danshen at various doses, a) Curves were plotted by the mean of 3 rat 
hearts per group, b) Data are tabulated by mean 士 SD of 3 rat hearts for each group. 
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a) 
8 —I  
i ^ ^ 
力 5 — C o n t r o l ^ ^ 
g) 1 mg/ml ^ ^ ^ 
4 4 . mg/ml Z 
1 - > < - 4 mg/ml 
Q I 獲 I 聚 I I I _. ‘ I ‘ ._  ‘ ‘ ‘ ...I I I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Accumulating leakage ofLDH (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0 . 2 6 土 0 . 1 2 0 .21 土 0 . 07 0 . 18 土 0 . 07 0 . 20 土 0 . 00 0 . 08 士 0 .01 0 . 20 土 0 . 09 
2 0 . 4 4 ± 0 . 13 0 . 3 5 士 0 .11 0 . 3 1 土 0 . 1 0 0 . 3 3 土 0 . 0 4 0 . 1 9 土 0 . 0 4 0 . 3 4 土 0 . 13 
3 0 . 65 士 0 . 1 4 0 . 5 4 土 0 . 17 0 .51 土 0 . 1 7 0 . 44 土 0 . 1 0 0 .31 土 0 . 09 0 . 67 士 0 . 19 
4 0 . 9 3 土 0 . 1 6 0 . 7 9 土 0 . 22 0 . 8 1 土 0 . 19 0 . 5 5 土 0 . 13 0 . 4 3 土 0 .11 1 . 1 2 ± 0 .21 
5 1 . 24土 0 . 1 8 1 .06土 0 . 2 8 1 .28土 0 . 20 0 . 6 7 土 0 . 1 6 0 . 5 8 土 0 . 12 1 . 6 4 ± 0 .25  
~ 6 1 . 5 8 ± 0 . 2 1 1 . 3 6 ± 0 . 3 5 1 . 5 9 ± 0 . 0 1 0 . 8 5 ± 0 . 27 0 . 7 2 ± 0 . 0 8 2 . 2 5 ± 0 . 3 0 
7 1 . 94土 0 . 23 1 .68土 0 . 45 1 .90土 0 . 08 1 .02土 0 .41 0 . 8 7 土 0 . 08 2 . 92土 0 . 3 6 
8 1 2 9 土 0 . 2 8 2 . 0 5 土 0 . 55 2 . 28土 0 . 1 4 1 . 2 6 ± 0 . 48 1.03 土 0 . 03 3 . 5 1 土 0 . 43 
9 2 . 6 4 土 0 . 3 5 2 . 39 士 0 . 67 2 . 56士 0 . 17 1 .53土 Q.67 1.21 土 0 . 0 4 4 . 1 5 土 0 . 5 0 
10 3 . 0 0 士 0 . 43 2 . 7 2 土 0 . 7 9 2 .85 土 0 . 2 0 1.71 土 0 . 7 9 1 .42 土 0 . 07 4 . 8 0 土 0 . 55  
~ 7 l 3.32 ± 0 . 5 3 3 . 0 7 ± 0 . 9 0 3 . 0 9 ± 0 . 2 7 1 . 9 3 ± 0 . 8 8 1 . 5 7 ± 0 . 1 6 5 . 3 4 ± 0.60 
12 3 . 65 土 0 . 63 3 . 3 9 土 1.01 3 .33 土 0 . 28 2 . 18 土 0 . 99 1.71 土 0 . 17 5 .81 土 0 .61 
13 3 . 98 土 0 . 6 9 3 . 68 土 1 .09 3 . 49 土 0 . 32 2 .47 土 1 .16 1.85 土 0 . 2 6 6 . 26 土 0 . 59 
14 4 . 2 7 士 0 . 7 7 3 . 9 7 土 1 .19 3 . 6 8 土 0 . 3 4 2 . 64土 1.21 2 . 0 7 土 0 . 3 9 6 . 68土 0 . 5 8 
15 4 . 5 5 士 0 . 8 0 4 . 2 3 土 1 .28 3 . 8 6 土 0 . 37 2 . 80 土 1 .32 2 . 2 0 土 0 . 45 7 .11 土 0 . 62 
Figure 4.8. Accumulating leakage of lactate dehydrogenase of ischemia-reperfusion 
injured heart protected by Danshen at various doses, a) Curves were plotted by the 
mean of 3 rat hearts per group, b) Data are tabulated by mean ± SD of 3 rat hearts for 
each group. 
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a) 
3 0 _.._..丨  
| i5 -
i ""•"Controf"! 
1 1 0 - + 2 mg/ml ^ ^ 
画 + 4 mg/ml 
0 11 -Hinwir I 風 I -J 1 1 1 1 1 I I . 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Accumulating leakage of CK (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0 . 5 4 土 0 . 2 9 0 . 3 1 土 0 . 1 3 0 . 2 8土 0 . 1 2 0 . 1 3 土 0 . 0 1 0 . 1 0 土 0 . 0 5 0 . 0 8土 0 . 1 3 
2 0 . 9 2 土 0 . 3 4 0 . 6 0 土 0 . 2 1 0 . 5 6士 0 . 1 9 0 . 3 1土 0 . 0 6 0 . 2 3 土 0 . 1 0 0 . 2 5 ± 0 . 2 0 
3 1 . 4 9土 0 . 3 7 1 . 0 2 土 0 . 3 3 0 . 9 8 土 0 . 3 3 0 . 6 4 土 0 . 1 4 0 . 3 8土 0 . 1 5 0 . 9 0土 0 . 3 3 
4 2.Z3土 0.43 1.65土 0.52 1.51 土 0.53 1.18土 0.51 0.63土 0.18 2.18土 0.52 
5 3 . 1 2 土 0 . 5 6 2 . 4 5土 0 . 7 6 2 . 3 1 士 0 . 8 5 1 . 9 0土 1 . 1 1 0 . 8 6土 0 . 2 3 4 . 0 6 土 0 . 8 0  
~ 6 4 . 1 3 土 0 . 7 4 3 . 3 3 ± 1 . 0 2 3 . 1 7 士 1 . 2 1 2 . 6 9 ± 1 . 6 7 1 . 0 7 ± 0 . 2 3 6 . 4 4 土 1 . 1 1 
7 5 . 2 0土 0 . 9 7 4 . 3 6 土 1 . 3 1 4 . 0 5 土 1 . 6 9 3 . 5 1 土 2 . 2 7 1 . 3 6土 0 . 2 8 9 . 0 8土 1 . 5 0 
8 6 . 3 0 土 1 . 2 3 5 . 4 4 土 1 . 6 3 4 . 9 9 土 2 . 1 9 4 . 3 5 土 2 . 8 7 1 . 6 9 土 0 . 2 7 1 1 . 5 5土 1 . 9 1 
9 7 . 4 2 土 1 . 5 4 6 . 5 2土 1 . 9 7 5 . 9 2 土 2 . 7 0 5 . 1 5 士 3 . 4 5 1 . 9 6 土 0 . 2 8 1 4 . 2 0土 2 . 3 4 
1 0 8 . 5 6 士 1.91 7 . 6 2 土 2 . 3 4 6 . 8 1 土 3.25 6.01 土 4.11 2.35土 0.21 16.61 土 2.80 
9 . 6 8 ± 2 . 3 7 8 . 6 9 ± 2 . 7 2 7 . 7 0 士 3 . 8 9 6 . 8 8 土 4 . 7 6 2 . 6 8 ± 0 . 2 7 1 8 . 6 3 ± 3 . 3 1 
1 2 1 0 . 7 5 土 2 . 7 4 9 . 7 7 土 3 . 0 8 8 . 4 3土 4 . 3 0 7 . 5 3土 5 . 1 8 3 . 0 0土 0 . 2 4 2 0 . 5 4 土 3 . 6 9 
1 3 1 1 . 7 4土 3 . 0 8 1 0 . 7 1 土 3 . 4 1 9 . 2 2土 4 . 7 4 8 . 4 1 土 5 . 5 3 3 . 3 6 士 0 . 1 4 2 2 . 3 0 土 4 . 0 7 
1 4 1 2 . 7 4土 3 . 4 2 1 1 . 6 2土 3 . 7 7 9 . 9 4 土 5 . 2 1 9 . 0 5土 5 . 9 0 3 . 7 1 土 0 . 0 1 2 3 . 9 3 土 4 . 4 9 
1 5 1 3 . 6 1 土 3 . 7 0 1 2 . 4 1 土 4 . 0 7 1 0 . 6 5 土 5 . 7 0 9 . 6 7土 6 . 2 6 4 . 1 3 土 0 . 1 3 2 5 . 3 5 土 4 . 8 9 
Figure 4.9. Accumulating leakage of creatine kinase of ischemia-reperfusion injured 
heart protected by Danshen at various doses, a) Curves were plotted by the mean of 3 
rat hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts for each 
group. 
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c) Gegen 
As shown in figures 4.10, 4.11，4.12 and 4.13，Gegen did not show obvious 
positive results to all four measured parameters, no enhancement on the recovery of 
both contractile force and coronary flow rate, and no reduction on the amount of 
leakage of both heart specific enzymes, i.e. lactate dehydrogenase and creatine kinase 
up to the dose of 16 mg/ml. 
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a) 
60%  
50% - ^  
j l k X ^ -•—Control 
I 1 mg/ml 
1 3 0 % - ^ ^ 
s 
1 0 % -
0% 1 1 1 1 1 1 1 i 1 1 1 I 1 I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (mm) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 55% ±18% 46% ±27% 49% ±19% 44% ±22% 46% 土 15% 52% ±20% 
2 44% ±17% 39% ±22% 36% ±16% 34% ±16% 37% ±18% 45% ±13% 
3 30% ±11% 30% ±9% 20% ±10% 21% ±9% 29% ±10% 34% ±13% 
4 22% 土 8% 25% ±6% 20% ±11% 20% ±9% 28% ±8% 23% ±8% 
5 21% ±7% 24% ±6% 20% ±8% 20% ±9% 28% ±8% 21% ±10%  
~ ~ 6 2 1 % ± 6 % 2 3 % ± 6 % 2 2 % ± 7 % 2 0 % ± 9 % ~ 2 3 % ± 9 % 2 1 % ±10% 
7 21% ±6% 22% ±9% 23% ±7% 20% ±8% 23% ±9% 22% ±7% 
8 22% ±5% 21% ±8% 20% ±7% 20% ±8% 22% ±7% 22% ±8% 
9 22% ±6% 21% ±8% 22% ±7% 20% ±8% 23% 士 7% 22% ±9% 
10 22% ±6% 21% ±8% 20% ±8% 25% ±13% 22% ±10% 22% ±9%  
~ n 2 2 % ± 6 % 2 1 % ± 7 % 2 3 % ± 8 % 2 0 % ± 9 % 2 3 % ±11% 22% ±8% 
12 22% 土 6% 21% 土 7% 23% 土 8% 20% ±8% 23% ±12% 22% ±8% 
13 23% ±6% 22% ±7% 25% ±9% 19% ±8% 23% ±13% 22% ±8% 
14 22% 土 9% 22% ±7% 25% ±9% 19% ±8% 23% ±10% 23% ±9% 
15 23% ±10% 22% ±7% 25% 土 11% 19% ±13% 25% ±6% 23% ±9% 
Figure 4.10. Contractile force recovery of ischemia-reperfusion injured heart 
protected by Gegen at various doses, a) Curves were plotted by the mean of 3 rat 
hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts for each group. 
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a) 
60%   
I: 
I" 20% - I — • — C o n t r o l 
2 - » - 1 mg/ml 
cj 
10% - - H - 4 mg/ml 
—*— 8 m^ml 
16 mg/ml I 
0% I I I I I I J 1 1 1 I I I I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 3 2 % ± 8 % 2 9 % ± 1 0 % 2 7 % ± 9 % 2 7 % ± 1 9 % 3 1 % ± 2 4 % 2 8 % ± 2 2 % 
2 4 1 % ± 1 2 % 3 4 % ± 1 1 % 3 2 % ± 1 2 % 3 3 % ± 1 3 % 5 3 % ± 2 2 % 3 1 % ± 1 8 % 
3 4 2 % ± 1 5 % 3 6 % ± 1 5 % 3 2 % ± 1 5 % 3 9 % 土 1 4 % 4 9 % ± 2 0 % 3 2 % ± 1 7 % 
4 4 2 % 土 1 8 % 3 6 % ± 2 1 % 3 4 % ± 2 0 % 4 1 % ± 1 4 % 4 3 % ± 1 8 % 3 3 % ± 1 6 % 
5 4 4 % ± 1 8 % 3 8 % 土 2 1 % 3 7 % ± 2 0 % 4 0 % ± 1 8 % 4 6 % ± 2 4 % 3 5 % ± 2 1 %  
~ 6 4 8 % ± 1 9 % 3 8 % ± 2 1 % 4 0 % ± 2 0 % 4 1 % ± 2 1 % 5 1 % ± 2 9 % 3 4 % ± 2 5 % 
7 4 9 % ± 1 6 % 4 0 % ± 2 1 % 4 3 % ± 1 9 % 4 2 % ± 2 0 % 4 6 % ± 2 7 % 3 5 % ± 2 4 % 
8 5 0 % ± 1 6 % 4 0 % ± 2 2 % 4 2 % ± 1 9 % 4 5 % ± 2 1 % 5 0 % ± 2 9 % 3 6 % ± 2 5 % 
9 5 1 % ± 1 6 % 4 0 % ± 2 1 % 4 3 % ± 1 9 % 5 4 % ± 2 1 % 4 6 % ± 2 5 % 3 5 % ± 2 3 % 
1 0 5 2 % ± 1 6 % 3 9 % ± 2 1 % 4 5 % ± 1 8 % 3 9 % ± 1 9 % 4 6 % ± 2 3 % 3 5 % ± 2 1 % 
1 1 5 2 % 土 1 6 % 4 2 % 士 1 9 % 4 2 % 土 1 8 % 4 4 % 土 2 0 % 4 5 % 土 2 2 % 3 5 % ± 2 1 % 
1 2 5 3 % ± 1 7 % 3 9 % ± 2 1 % 5 1 % ± 1 9 % 3 4 % ± 1 9 % 4 5 % ± 1 9 % 3 7 % ± 1 9 % 
1 3 5 3 % ± 1 7 % 4 0 % ± 2 1 % 4 5 % ± 1 9 % 4 1 % ± 1 7 % 4 5 % ± 1 7 % 3 5 % ± 1 7 % 
1 4 5 4 % ± 1 7 % 4 0 % ± 2 0 % 5 3 % ± 1 9 % 4 0 % 土 1 7 % 4 5 % ± 1 7 % 3 7 % 土 1 7 % 
1 5 5 3 % ± 1 7 % 4 1 % ± 2 1 % 4 0 % ± 1 9 % 3 9 % ± 1 4 % 4 5 % ± 1 3 % 3 6 % ± 1 4 % 
Figure 4.11. Coronary flow rate recovery of ischemia-reperfusion injured heart 
protected by Gegen at various doses, a) Curves were plotted by the mean of 3 rat 
hearts per group, b) Data are tabulated by mean 士 SD of 3 rat hearts for each group. 
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I 3 I - - C o n t r o l 
S - - m - 1 mg/ml 
g) - ^ 2 mg/ml 
； 2 - mg/ml j t ^ ^ f T ^ ^ 
1 mg/ml 
I 1 I — 1 6 mg/ml I 
0 1 I I I I I 1 i 1 1 L_ I I I  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Accumulating leakage ofLDH (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0 . 2 6 土 0 . 1 2 0 . 2 1 土 0 . 0 4 0 . 1 9土 0 . 0 4 0 . 2 5士 0 . 0 4 0 . 2 0 土 0 . 0 4 0 . 1 9土 0 . 0 6 
2 0 . 4 4 士 0 . 1 3 0 . 3 8 土 0 . 0 6 0 . 3 0 土 0 . 0 7 0 . 4 3 土 0 . 0 6 0 . 3 7 士 0 . 0 6 0 . 3 0 土 0 . 1 0 
3 0 . 6 5 ± 0 . 1 4 0 . 6 0 ± 0 . 0 9 0 . 4 8 ± 0 . 1 0 0 . 6 8 土 0 . 0 9 0 . 5 4 土 0 . 0 9 0 . 4 4 土 0 . 1 5 
4 0 . 9 3 土 0 . 1 6 0 . 9 0 土 0 . 1 2 0 . 7 9 土 0 . 1 1 0 . 9 5 土 0 . 1 0 0 . 6 8 土 0 . 1 0 0 . 7 0 土 0 . 1 6 
5 1 . 2 4土 0 . 1 8 1 . 2 3 ± 0 . 1 2 1 . 1 0土 0 . 1 3 1 . 2 5土 0 . 1 2 0 . 8 3 土 0 . 1 2 0 . 9 9士 0 . 1 9 
~ 6 1 . 5 8 ± 0 . 2 1 1 . 5 7 ± 0 . 1 1 1 . 4 2 ± 0 . 1 5 1 . 4 9 ± 0 . 1 4 1 . 1 3 土 0 . 1 4 1 . 3 6 ± 0 . 2 3 
7 1 . 9 4 土 0 . 2 3 1 . 9 1 土 0 . 0 8 1 . 7 7 土 0 . 1 8 1 . 7 6 土 0 . 1 6 1 . 4 3 土 0 . 1 7 1 . 7 3 土 0 . 2 8 
8 2 . 2 9 土 0 . 2 8 2.：30土 0 . 1 1 1 1 0 土 0 . 2 2 1 0 7 土 0 . 1 9 1 / 7 3 土 0 . 2 0 2 . 1 6 士 0 . 3 5 
9 2 . 6 4 土 0 . 3 5 2 . 6 2 土 0 . 1 4 2 . 4 3 土 0 . 2 5 2 . 3 7 土 0 . 2 1 2 . 2 0 土 0 . 2 3 2 . 5 5 土 0 . 4 1 
1 0 3.00 土 0 . 4 3 2.92 土 0 . 1 9 2 . 7 5 士 0 . 2 8 2 . 6 8 土 0 . 2 3 2.50 土 0.25 197 土 0.45  
~ T l 3 . 3 2 土 0.53 3.24土 0.19 3.09 土 0 . 3 0 2 . 9 5士 0.26 2.81 土 0.28 3.39土 0.48 
1 2 3 . 6 5 土 0 . 6 3 3 . 4 7 土 0 . 1 9 3 . 3 7 ± 0 . 3 0 3 . 2 1 ± 0 . 2 7 3 . 1 7 土 0 . 2 9 3 . 8 3 土 0 . 4 8 
1 3 3 . 9 8 士 0 . 6 9 3 . 7 2 ± 0 . 1 7 3 . 6 3士 0 . 3 0 3 . 4 6土 0 . 2 6 3 . 6 2 土 0 . 2 8 4 . 1 7 土 0 . 4 7 
1 4 4 . 2 7 土 0 . 7 7 3 . 9 3 土 0 . 1 7 3 . 9 1 土 0 . 2 9 3 . 7 3 土 0 . 2 6 3 . 8 5 土 0 . 2 7 4 . 4 2 土 0 . 4 6 
1 5 4 . 5 5 土 0 . 8 0 4 . 1 8 土 0 . 2 2 4 . 1 9 土 0 . 3 1 3 . 9 8 土 0 . 2 8 4 . 1 2 土 0 . 2 9 4 . 7 7 土 0 . 4 9 
Figure 4.12. Accumulating leakage of lactate dehydrogenase of ischemia-reperfusion 
injured heart protected by Gegen at various doses, a) Curves were plotted by the mean 
of 3 rat hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts for each 
group. 
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a) 
16 j —          
i：： 
^ I - • - C o n t r o l 1 
1 8 - _B_img/ml 
M - A - 2 mg/ml 
•B 6 - X - 4 mg/ml 
3 - * - 8 m g / m l 
0 1, I ‘ •__I 1 I 1 1 1 1 1 1 1 1 I 1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Accumulating leakage of CK (U) 
Time Control 1 mg/ml 2 mg/ml 4 mg/ml 8 mg/ml 16 mg/ml 
1 0.54土 0.29 0.31 土 0.21 0.30土 0.06 0.29 土 0.11 0.29土 0.20 0.32 土 0.04 
2 0 . 9 2 士 0 . 3 4 0 . 6 3 土 0 . 2 7 0 . 7 6土 0 . 0 8 0 . 4 1 ± 0 . 1 8 0 . 6 4土 0 . 2 7 0 . 6 4 土 0 . 0 6 
3 1.49土 0.：37 1.16 土 0.35 1.52土 0.1：3 O/M土 0.31 1.16土 0.34 1.19 士 0.11 
4 2 . 2 3 土 0 . 4 3 1 . 9 6土 0 . 4 8 2 . 3 4土 0 . 3 4 1 . 3 6土 0 . 5 1 1 . 9 6土 0 . 4 7 1 . 9 3土 0 . 3 3 
5 3 . 1 2 土 0 . 5 6 2 . 9 5土 0 . 6 6 3 . 1 3士 0 . 5 9 2 . 0 2土 0 . 7 9 2 . 9 5土 0 . 6 5 2 . 8 7土 0 . 5 7 
6 4.13土 0.74 4.01 土 0.88 4.08士 0.96 2.64土 U 0 4.14土 0.88 3.84 土 0.94 
7 5.20土 0.97 5.18 土 1.14 5.04土 1.26 3.78 士 1.48 5.58 士 1.13 4.87 士 1.25 
8 6.30土 1.23 6.41 土 1.43 6.02土 1.67 5.11 土 1.89 7.11 土 1.42 6.10 士 1.66 
9 7.42土 1.54 7.51 土 1.76 6.99 土 2.04 6.42土 2.32 8.52土 1.75 7.06土 2.02 
10 8.56土 1.91 8.47土 2.13 7.97土 2.30 7.79土 2.78 9.69土 2.12 7.98土 Z28  
~ 1 1 9.68 ± 2 . 3 7 9 . 3 9 ± 2 . 5 4 8 . 9 3 ± 2 . 6 6 9 . 0 7 ± 3 . 2 9 1 0 . 7 7 ± 2 . 5 4 8 . 8 4 ± 2.64 
12 10.75土 2.74 10.21 土 2.91 10.01 土 2.87 10.33 士 3.68 11.67土 2.90 9.61 土 2.86 
1 3 1 1 . 7 4 ± 3 . 0 8 1 0 . 9 9 ± 3 . 2 4 1 0 . 9 1 土 3 . 1 5 1 1 . 3 6 ± 4 . 0 6 1 2 . 4 9 ± 3 . 2 4 1 0 . 3 7土 3 . 1 3 
14 12.74土 3.42 11.66士 3.60 11.82士 3.36 12.16土 4.48 13.09 士 3.59 11.08± 3.35 
15 13.61 士 3.70 12.36± 3.89 12.62土 3.58 12.84士 4.87 13.72 士 3.88 11.86土 3.57 
Figure 4.13. Accumulating leakage of creatine kinase of ischemia-reperfusion injured 
heart protected by Gegen at various doses, a) Curves were plotted by the mean of 3 rat 
hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts for each group. 
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d) Comparison among the three samples 
The dose response of three samples, 7:3 (D:G) compound formula, Danshen (D) 
and Gegen (G), was illustrated in the previous part of results. 7:3 (D:G) compound 
formula and Danshen showed high level of protection at the dose of 8 mg/ml, so the 
effectiveness of them was compared in this part at the dose 8 mg/ml. 
As shown in figure 4.14，Gegen did not show any enhancement on the contractile 
force recovery, as it exhibited nearly the same percentage as the control at around 
20%. While the 7:3 (D:G) compound formula and Danshen in the dose of 8 mg/ml 
showed nearly same contractile force recovery of about 60%. Almost the contractile 
force recovery of 7:3 (D:G) compound formula and Danshen were the same except in 
the first few minutes. Danshen gave a better percentage recovery at the third to fifth 
minutes. 
As shown in figure 4.15, Gegen did not show any enhancement on the coronary 
flow rate recovery, as it exhibited nearly the same percentage as the control at around 
50%. While the 7:3 (D:G) compound formula and Danshen in the dose of 8 mg/ml 
showed nearly same contractile force recovery at the first four minutes of reperfusion 
that rose from 50% to 100%. After the fourth minute, the curve of 7:3 (D:G) 
compound formula became flattened at around 110% while the curve of Danshen 
continuously rose up to 140% at the ninth minute. 
As shown in the figure 4.16, Gegen did show slightly reduction on the 
accumulating leakage of lactate dehydrogenase where 4.1 U of Gegen comparing to 
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4.5 U of control. The 7:3 (D:G) compound formula reduced the lactate dehydrogenase 
amount to 3.3 U. Danshen was the most effective one, it reduced the lactate 
dehydrogenase amount to 2.2 U. The protective effectiveness of them was clearly 
shown in descending order of Danshen, 7:3 (D:G) compound formula and Gegen in 
this part of lactate dehydrogenase amount measurement. 
As shown in figure 4.17, Gegen did not show reduction on the accumulating 
leakage of creatine kinase where 13.7 U of Gegen comparing to 13.6 of control. The 
7:3 (D:G) compound formula reduced the creatine kinase amount to 6.2 U. Danshen 
was the most effective one, it reduced the creatine kinase amount to 4.1 U. The 
protective effectiveness of them was clearly showed in descending order of Danshen, 
7:3 (D:G) compound formula and Gegen in this part of creatine kinase amount 
measurement. 
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10% - A - D a n s h e n 
— G e g e n 
0% I ,1, 1 1 1 1 1 1 1 1 1 1 1  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Contractile force recovery (%) 
Time Control 7:3 (D:G) Danshen Gegen 
1 0 . 5 5 土 0 . 1 8 0 . 8 9土 0 . 0 7 0 / 7 5 土 0 . 1 9 0 . 4 6土 0 . 1 5 
2 0.44 土 0.17 0.69土 0.27 0/73土 0.22 0.J7土 0.18 
3 0 . 3 0士 0 . 1 1 0 . 6 1 土 0 . 2 4 0 . 7 3土 0 . 2 0 0 . 2 9 土 0 . 1 0 
4 0 . 2 2 土 0 . 0 8 0 . 5 7 ± 0 . 2 1 0 . 7 1 士 0 . 1 7 0 . 2 8 土 0 . 0 8 
5 0.21 土 0.07 0.M 土 0.19 0.68土 0.10 0.28土 0.08  
~~6 0.21 ± 0 . 0 6 0 . 5 4 ± 0 . 2 0 0 . 5 1 ± 0 . 2 6 0 . 2 3 ± 0.09 
7 0 . 2 1 ± 0 . 0 6 0 . 5 3 土 0 . 1 6 0 . 5 1 士 0 . 2 5 0 . 2 3 土 0 . 0 9 
8 0 . 2 2 土 0 . 0 5 0 . 5 4 土 0 . 1 6 0 . 5 2 土 0 . 2 7 0 . 2 2 土 0 . 0 7 
9 0 . 2 2 土 0 . 0 6 0 . 5 6土 0 . 1 6 0 . 5 4土 0 . 2 9 0 . 2 3土 0 . 0 7 
1 0 0 . 2 2 士 0 . 0 6 0 . 5 8 土 0 . 1 6 0 . 5 5土 0 . 3 0 0 . 2 2 士 0 . 1 0  
~ T l 0.22 ± 0 . 0 6 0 . 5 9土 0 . 1 7 0 . 5 6 ± 0.31 0.23 ± 0.11 
1 2 0 . 2 2 土 0 . 0 6 0 . 6 1土 0 . 1 8 0 . 6 3 土 0 . 2 4 0 . 2 3 土 0 . 1 2 
1 3 0 . 2 3 土 0 . 0 6 0 . 6 3 土 0 . 1 9 0 . 6 6土 0 . 2 7 0 . 2 3土 0 . 1 3 
1 4 0 . 2 2 土 0 . 0 9 0 . 6 5 ± 0 . 1 8 0 / 7 2土 0 . 2 1 0 . 2 3土 0 . 1 0 
1 5 0 . 2 3 土 0 . 1 0 0 . 6 6土 0 . 1 8 0 . 6 8土 0 . 2 9 0 . 2 5 土 0 . 0 6 
Figure 4.14. Comparison of the protective effect on the contractile force recovery of 
7:3 (D:G) compound formula, Danshen (D) and Gegen (G). a) Curves were plotted by 
the mean of 3 rat hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts 
for each group. 
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QP/^  1 I I 1 1 1 1 1 1 1 1 I I I 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
b) 
Coronary flow rate recovery (%) 
Time Control 7:3 (D:G) Danshen Gegen 
1 0 . 3 2 土 0 . 0 8 0 . 5 3 士 0 . 2 7 0 . 5 0 土 0 . 2 7 0 . 3 1 土 0 . 2 4 
2 0 . 4 1 土 0 . 1 2 0 . 6 7土 0.：25 0 . 6 2土 0 . 2 3 0 . 5 3土 0 . 2 2 
3 0 . 4 2 土 0 . 1 5 0 . 8 4 土 0 . 2 3 0 . 8 5土 0 . 2 5 0 . 4 9土 0 . 2 0 
4 0 . 4 2 土 0 . 1 8 1 . 0 2 ± 0 . 2 1 1 . 0 1 土 0 . 4 6 0 . 4 3 ± 0 . 1 8 
5 0 . 4 4 土 0 . 1 8 1 . 0 5 士 0 . 2 7 1 . 1 1 土 0 . 3 9 0 . 4 6土 0 . 2 4  
~ ~ 6 0 . 4 8 ± 0 . 1 9 1 . 1 2土 0 . 3 2 1 . 2 3 ± 0 . 2 7 0 . 5 1 ± 0 . 2 9 
7 0 . 4 9土 0 . 1 6 1 . 1 6土 0 . 3 0 1 . 3 4 土 0 . 1 5 0 . 4 6 土 0 . 2 7 
8 0 . 5 0 ± 0 . 1 6 1 . 1 8土 0 . 3 2 1.：38士 0 . 1 7 0 . 5 0土 0 . 2 9 
9 0.:51 土 0 . 1 6 1 . 1 2土 0 . 2 8 1 . 4 2土 0 . 0 4 0 . 4 6土 0 . 2 5 
1 0 0 . 5 2 土 0 . 1 6 1 . 1 2土 0 . 2 6 1 . 4 4土 0 . 0 5 0 . 4 6 ± 0 . 2 3  
~ ~ 1 1 0 . 5 2 土 0 . 1 6 1 . 1 1 土 0 . 2 5 1 . 4 2 土 0 . 0 4 0 . 4 5 ± 0 . 2 2 
1 2 0 . 5 3 ± 0 . 1 7 1 . 0 8 土 0 . 2 2 1 . 4 9 土 0 . 0 2 0 . 4 5 土 0 . 1 9 
1 3 0 . 5 3 土 0 . 1 7 1 . 0 7土 0 . 2 0 1 . 3 9土 0 . 0 6 0 . 4 5土 0 . 1 7 
1 4 0 . 5 4 土 0 . 1 7 1 . 0 1 土 0 . 2 0 1 . 4 7土 0 . 1 4 0 . 4 5 土 0 . 1 7 
1 5 0 . 5 3 土 0 . 1 7 1 . 0 2土 0 . 1 6 1 . 3 1 土 0 . 1 6 0 . 4 5土 0 . 1 3 
Figure 4.15. Comparison of the protective effect on the coronary flow rate recovery of 
7:3 (D:G) compound formula, Danshen (D) and Gegen (G). a) Curves were plotted by 
the mean of 3 rat hearts per group, b) Data are tabulated by mean 土 SD of 3 rat hearts 
for each group. 
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Time (min) 
b) 
Accumulating leakage ofLDH (U) 
Time Control 7:3 (D:G) Danshen Gegen 
1 0 . 2 6 土 0 . 1 2 0 . 2 3土 0 . 0 9 0 . 0 8 土 0 . 0 1 0 . 2 0土 0 . 0 4 
2 0 . 4 4 土 0 . 1 3 0 . 3 7土 0 . 1 1 0 . 1 9土 0 . 0 4 0 . 3 7 土 0 . 0 6 
3 0 . 6 5土 0 . 1 4 0 . 5 5 土 0 . 1 5 0 . 3 1 土 0 . 0 9 0 . 5 4 土 0 . 0 9 
4 0 . 9 3 士 0 . 1 6 0 . 7 8 ± 0 . 1 8 0 . 4 3土 0 . 1 1 0 . 6 8土 0 . 1 0 
5 1 . 2 4土 0 . 1 8 1 . 0 1 土 0 . 2 0 0 . 5 8土 0 . 1 2 0 . 8 3 ± 0 . 1 2  
~ 6 1 . 5 8 ± 0 . 2 1 1 . 2 9 ± 0 . 2 6 0 . 7 2 ± 0 . 0 8 1 . 1 3 土 0 . 1 4 
7 1 . 9 4土 0 . 2 3 1 . 5 3 土 0 . 2 5 0 . 8 7土 0 . 0 8 1 . 4 3 土 0 . 1 7 
8 2 . 2 9 ± 0 . 2 8 1 . 7 8 ± 0 . 2 5 1 . 0 3 ± 0 . 0 3 1 . 7 3 土 0 . 2 0 
9 2 . 6 4 土 0 . 3 5 1 . 9 9 土 0 . 2 5 1 . 2 1 土 0 . 0 4 2 . 2 0 土 0 . 2 3 
1 0 3 . 0 0 士 0 . 4 3 2 . 2 1 土 0 . 2 7 1 . 4 2 士 0 . 0 7 2 . 5 0 士 0 . 2 5  
~ T l 3 . 3 2 ± 0 . 5 3 2 . 4 9 ± 0 . 3 4 1 . 5 7 土 0 . 1 6 2 . 8 1 ± 0 . 2 8 
1 2 3 . 6 5士 0 . 6 3 2 . 7 4土 0 . 4 0 1 . 7 1 土 0 . 1 7 3 . 1 7土 0 . 2 9 
1 3 3 . 9 8 ± 0 . 6 9 2 . 9 4 ± 0 . 3 7 1 . 8 5 ± 0 . 2 6 3 . 6 2 ± 0 . 2 8 
1 4 4 . 2 7 土 0 . 7 7 3 . 1 1 土 0 . 3 8 2 . 0 7土 0 . 3 9 3 . 8 5士 0 . 2 7 
1 5 4 . 5 5 土 0 . 8 0 3 . 3 2 土 0 . 4 3 2 . 2 0 土 0 . 4 5 4 . 1 2 土 0 . 2 9 
Figure 4.16. Comparison of the protective effect on the accumulating leakage of 
lactate dehydrogenase of 7:3 (D:G) compound formula, Danshen (D) and Gegen (G). 
a) Curves were plotted by the mean of 3 rat hearts per group, b) Data are tabulated by 
mean 土 SD of 3 rat hearts for each group. 
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5 3 . 1 2 ± 0 . 5 6 1 . 4 7土 0 . 3 7 0 . 8 6土 0 . 2 3 2 . 9 5土 0 . 6 5 
6 4 . 1 3 士 0 . 7 4 1 0 0 ± 0 . 4 3 1 . 0 7土 0 . 2 3 4 . 1 4土 0 . 8 8 
7 5 . 2 0 土 0 . 9 7 2 . 4 1 土 0 . 6 0 1 . 3 6土 0 . 2 8 5 . 5 8土 1 . 1 3 
8 6 . 3 0 土 1 . 2 3 2 . 9 1 土 0 . 7 3 1 . 6 9 土 0 . 2 7 7 . 1 1 土 1 . 4 2 
9 7 . 4 2 土 1 . 5 4 3 . 3 5土 0 . 8 9 1 . 9 6土 0 . 2 8 8 . 5 2土 1 . 7 5 
1 0 8 . 5 6土 1 . 9 1 3 . 7 8 ± 1 . 0 2 2 . 3 5土 0 . 2 1 9 . 6 9土 2 . 1 2 
1 1 9 . 6 8土 2 . 3 7 4 . 1 9土 1 . 1 5 2 . 6 8 土 0 . 2 7 1 0 . 7 7土 2 . 5 4 
1 2 1 0 . 7 5土 2 . 7 4 4 . 7 2 土 1 . 2 1 3 . 0 0土 0 . 2 4 1 1 . 6 7 士 2 . 9 0 
1 3 1 1 . 7 4土 3 . 0 8 5 . 2 2土 1 . 3 6 3 . 3 6土 0 . 1 4 1 2 . 4 9土 3 . 2 4 
1 4 1 2 . 7 4士 3 . 4 2 5 . 7 0 ± 1 . 4 3 3 . 7 1 土 0 . 0 1 1 3 . 0 9土 3 . 5 9 
1 5 1；3.61 土 3 / 7 0 6 . 1 7 土 1.:57 4 . 1 3 土 0 . 1 3 1 3 / 7 2土 
Figure 4.17. Comparison of the protective effect on the accumulating leakage of 
creatine kinase of 7:3 (D:G) compound formula, Danshen (D) and Gegen (G). a) 
Curves were plotted by the mean of 3 rat hearts per group, b) Data are tabulated by 
mean 土 SD of 3 rat hearts for each group. 
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4.2.3 Discussion 
The 7:3 (D:G) compound formula was not as protective as Danshen in the 
ischemia-reperfusion rat heart model that demonstrated in the heart specific enzyme 
studies. Although Gegen did not show positive protective effects, at least the 
protective effect of 7:3 (D:G) compound formula did not show a sudden drop due to 
the presence of Gegen. Gegen did not show positive protection in this part. However, 
the 7:3 (D:G) compound formula showed similar protective effect to Danshen giving 
around 60% contractile force recovery. As 7:3 (D:G) compound formula was 
extracted by a mixture which only contained 70% Danshen by mass, there may be 
some supplementary effects coming from the Gegen ingredient or some compounds in 
Gegen can enhance the action of Danshen to restore the contractile force. 
Patients having myocardial infraction may suffer from ischemia-reperfusion 
heart injury. The protective effect of the 7:3 (D:G) compound formula may be useful 
as it showed a very good contractile force recovery and coronary flow recovery. It 
also reduced the amount of heart cells damage which was reflected by the lactate 
dehydrogenase and creatine kinase studies. 
Patients after angioplasty procedure may also form a case of reperfusion injury to 
the heart. The 7:3 (D:G) compound formula may also be useful for them. Further 
clinical studies are needed to prove this hypothesis. 
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Chapter 5 Vasodilation study 
Only 6 years after the discovery of endothelial-derived relaxing factor (EDRP), it 
became apparent that many cardiovascular diseases are associated with an impairment 
of endothelium-dependent vasorelaxation. This has been shown in 
hypercholesterolemic rabbits and monkeys and in patients having coronary artery 
disease or typical risk factors predisposing to this condition. Endothelium-dependent 
vasorelaxation is also abnormal in other disease states such as heart failure, diabetes 
mellitus and hypertension (Moncada and Higgs, 1993). Presumably, there is a loss of 
endothelial production and/or bioavailability of NO (nitric oxide, nitrogen monoxide) 
in these disorders. 
Vasodilation is the best documented activity of NO in the cardiovascular system. 
This action led to the discovery of endothelium-derived relaxing factor 20 years ago 
(Furchgott and Zawadzki, 1980). Subsequent research has shown that endogenous NO 
production is involved in the regulation of local vasomotion and blood pressure. 
Numerous conditions characterized by an impaired availability of NO have been 
found to be associated with enhanced synthesis of endothelin-1 (ET-1) as a potent 
endogenous vasoconstrictor (Rossi et al., 2001). Pharmacological inhibition of 
endogenous NO synthesis has been shown to induce a rise in blood pressure in man 
(Stamler et al., 1994) and disruption of the endogenous NO synthase (eNOS) gene by 
the�knock-out’ technique causes mild hypertension in mice (Huang et al, 1995). 
Elevated blood pressure is a well known risk factor for the development of 
cardiovascular diseases such as stroke and myocardial infarction, while a reduction of 
blood pressure is effective in reducing morbidity and mortality of cardiovascular 
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diseases (Kaimel, 2000). Thus, maintenance of normal blood pressure by endothelial 
NO may be considered as part of its vasoprotective action. Therefore the vasodilation 
effects of drugs are of interest and need to be investigated. 
NO is a soluble gas that diffuses freely in both water and lipid and has a half-life 
of only a few seconds. It is synthesized from the amino acid L-arginine by nitric oxide 
synthase (NOS) (Palmer et al., 1987). Two main forms of vascular NOS have been 
described, namely the calcium calmodulin-dependent constitutive NOS (eNOS) 
present in endothelial cells and the calcium-independent inducible NOS (iNOS). The 
iNOS is primarily expressed in immune cells and vascular smooth muscle cells 
(VSMC). NO diffuses to the VSMC inducing the formation of cyclic guanosine 
monophosphate. This, in turn, activates protein kinase C resulting in a decline in 
intracellular ionized calcium in the VSMC leading to relaxation and vasodilation 
(Moncada et al., 1993 and Moncada et al., 1991). The basal NO production can be 
upregulated by physical forces, such as shear stress, as well as by several 
receptor-operating transmitters and hormones such as estrogen, acetylcholine, 
bradykinin, substance P, serotonin, adrenaline and noradrenaline, adenosine and 
thromboxane (Liischer and Noll 1995 ； Rubanyi et al, 1986). 
Therefore the involvment of endothelium and nitric oxide of the vasodilation 
effect of the 7:3 (D:G) compound formula were also interested for investigation in the 
second part of this chapter. 
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5.1 Vasodilation in organ bath 
For long-term prevention of cardiovascular disease, controlling the blood 
pressure is very important. Higher blood pressure represents higher risk of 
atherosclerosis as higher turbulence occurs in the blood vessel (Spence et al., 1984). 
In addition, cardiovascular diseases are always complicated with impaired blood 
vessel endothelium function and loss of vasodilation ability at certain degree. 
Restoration of vasodilation ability is beneficial to hypertension patients (Antony et al, 
1996). 
The vasodilation effect of 7:3 (D:G) compound formula, Danshen aqueous and 
Gegen aqueous extract were investigated by the ex-vivo organ bath setup. 
5.1.1 Materials and Methods 
Chemicals 
(R)-(-)-phenylephrine hydrochloride (Phe), acetylcholine chloride (Ach) and 
9,11 -dideoxy-9a, 11 a-epoxymethano prostaglandin F2a (U46619) were purchased from 
Sigma. Krebs solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgS04, 1.2 mM 
KH2PO4, 5.55 mM D-glucose, 25.0 mM NaHCOs and 2.5 mM CaCb) was adjusted to 
pH 7.4 and filtered. 
Amimal 
Aorta was excised from 300 g male Sprague-Dawley (SD) rats and placed in 
Krebs solution. After fat and connective tissue were removed, aorta was cut into 1 
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mm width rings. The isolated aorta rings were mounted between two wires in organ 
bath. The condition was maintained at 2>TC Krebs solution and was gassed with 
mixture of 95% O2 and 5% CO2. The tension was slowly adjusted mechanically up to 
1 g with an increasing rate not more then 0.2 g each 5 minute intervals. Finally 1 g 
basal tension was applied to the aorta rings. 
Pre-test 
The validity of the aorta rings was confirmed by contraction with 0.3 |j,M 
phenylephrine and then relaxation with 0.3 jiM acetylcholine. If 70% or more 
relaxation was shown when comparing to the 0.3 |xM phenylephrine induced 
contraction, the aorta ring was defined to be suitable for further use as the endothelial 
layer remained intact. Aorta ring was then equilibrated for an hour with three times 
changing Krebs solution before the test of samples. 
Drug test 
The aorta rings were contracted by 10 nM U46619, which is a potent 
prostaglandin H2 receptor agonist, for 20 minutes. Samples were then added to the 
organ bath and the vasomotion were monitored throughout the experiment. Samples 
were prepared by Krebs solution. 
Measurement 
Tensions were recorded by MacLab data acquisition system through Grass 
force-displacement transducers, FT-03E. Data was recorded by a sampling rate of 10 
per second. The background noise of raw data was then removed by triangular 
(Bartlett) window type of smoothing with window size of 201 points width before 
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analysis. Finally, results were expressed as percentage relaxation response of the 
maximal contraction induced by 10 nM U46619. 
5.1.2 Results 
Dose response vasodilation of aqueous extract of 7:3 (D:G) compound formula, 
Danshen and Gegen were investigated. 
a) 7:3 (D:G) compound formula 
Effects of formula concentrations on vasodilation were investigated at 0.5 mg/ml, 
1 mg/ml, 2 mg/ml, 3 mg/ml and 4 mg/ml. The vasodilation effect of them was very 
slow at the low doses, namely 0.5 mg/ml and 1 mg/ml, while faster responses were 
given at higher doses. Dose dependent manner could be clearly observed from the 
screenshot of the computerized MacLab system as shown in figure 5.1. The time 
taken to obtain 70% relaxation from maximum U44619 induced vasoconstriction was 
compared as illustrated in table 5.1. The time for 70% relaxation was reduced from 
108 minutes to 14 minutes when the dose increased from 0.5 mg/ml to 4 mg/ml. Rate 
of vasodilation was also shown in table 5.1 and it was calculated by 70% divided by 
the time taken to give 70% relaxation. The unit of the rate was defined as percentage 
relaxed per minute. A plot of rate relaxation against 7:3 (D:G) formula concentration 
was shown in figure 5.2. Linear regression was indicated as R^=0.992, the linear 
relationship was very clearly shown. 
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Figure 5.1. Screenshot of the MacLab system showing the dose response vasodilation 
of the 7:3 (D:G) compound formulae. Vertical dimension represents the tension force 
of the aorta ring in the unit of gram (g) and the horizontal dimension represents the 
time course during the experiment. Formula concentrations 0.5 mg/ml, 1 mg/ml, 2 
mg/ml, 3 mg/ml and 4 mg/ml were respectively added in channel 1 to 5. Dose 
dependent manner can be clearly observed. 
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Cone, (mg/ml) Time (min) Rate (%mm^) 
0.5 108±12.29 0.66土 0.08 
1 58±3.56 1.21 ±0.07 
2 32±2.50 2.18±0.17 
3 1811.71 3.86 土 0.38 
4 14±1.41 5.04 土 0.55 
Table 5.1. Time required for various concentration of 7:3 (D:G) compound formula to 
give a 70% vasodilation. Rate represents 70%/time, that is the percentage relax per 
minute. Data are mean 土 SD of 4 aorta rings each group. 
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Figure 5.2. Linear dose-relaxation relationship between vasodilation rate and 7:3 (D:G) 
formula concentration. Data are mean 土 SD of 4 aorta rings each group. R^=0.992 
implies linear relationship obtained. 
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b) Danshen aqueous extract 
Effects of Danshen concentrations on vasodilation were investigated at 0.5 
mg/ml, 1 mg/ml, 2 mg/ml, 3 mg/ml and 4 mg/ml. The vasodilation effect of them was 
very slow at the low doses, namely 0.5 mg/ml and 1 mg/ml, while faster responses 
were given at higher doses. Dose dependent manner could be clearly observed from 
the screenshot of the computerized MacLab system as shown in figure 5.3. The time 
taken to obtain 70% relaxation from maximum U44619 induced vasoconstriction was 
compared as illustrated in table 5.2. The time for 70% relaxation was reduced from 99 
minutes to 20 minutes when the dose increased from 0.5 mg/ml to 4 mg/ml. Rate of 
vasodilation was also shown in the table 5.2 and it was calculated by 70% divided by 
the time taken to give 70% relaxation. The unit of the rate was defined as percentage 
relaxed per minute. A plot of rate relaxation against Danshen concentration was 
shown in figure 5.3 Linear regression was indicated as R^=0.9944, the linear 
relationship was very clearly shown. 
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Figure 5.3. Screenshot of the MacLab system showing the dose response vasodilation 
of the Danshen aqueous extract. Vertical dimension represents the tension force of the 
aorta ring in the unit of gram (g) and the horizontal dimension represents the time 
course during the experiment. Formula concentrations 0.5 mg/ml, 1 mg/ml, 2 mg/ml 
and 4 mg/ml were respectively added in channel 1 to 4. Dose dependent manner can 
be clearly observed. 
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Cone, (mg/ml) Time (min) Rate (%min-l) 
0.5 98.50±4.51 0.71±0.03 
1 60.25±6.40 U7±0.13 
2 37.25±4.93 1.89±0.25 
3 27.50土2.08 2.56±0.19 
4 19.75±1.71 3.56±0.30 
Table 5.2. Time required for various concentration of Danshen aqueous extract to give 
a 70% vasodilation. Rate represents 70%/time, that is the percentage relax per minute. 
Data are mean 土 SD and of 4 aorta rings each group. 
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Figure 5.4. Linear dose-relaxation relationship between vasodilation rate and Danshen 
aqueous extract concentration. Data are mean 士 SD and of 4 aorta rings each group. 
R2=0.9944 implies linear relationship obtained. 
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c) Gegen aqueous extract 
Effects of Gegen concentrations on vasodilation were investigated at 1 mg/ml, 2 
mg/ml, 4 mg/ml, 6 mg/ml and 8 mg/ml. The vasodilation effect of them was very 
slow at the low doses, namely 1 mg/ml and 2 mg/ml while faster responses were 
given at higher doses. Dose dependent manner could be clearly observed from the 
screenshot of the computerized MacLab system as shown in figure 5.5. The time 
taken to obtain 70% relaxation from maximum U44619 induced vasoconstriction was 
compared as illustrated in table 5.3. The time for 70% relaxation was reduced from 
118 minutes to 14 minutes when the dose increased from 1 mg/ml to 8 mg/ml. Rate of 
vasodilation was also shown in the table 5.3 and it was calculated by 70% divided by 
the time taken to give 70% relaxation. The unit of the rate was defined as percentage 
relaxed per minute. A plot of rate relaxation against Gegen concentration was shown 
in figure 5.6. Linear regression was indicated as R =0.9903, the linear relationship 
was very clearly shown. 
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Figure 5.5. Screenshot of the MacLab system showing the dose response vasodilation 
of the Gegen extract. Vertical dimension represents the tension force of the aorta ring 
in the unit of gram (g) and the horizontal dimension represents the time course during 
the experiment. Formula concentrations 1 mg/ml, 2 mg/ml, 3 mg/ml, 4 mg/ml and 8 
mg/ml were respectively added in channel 1 to 5. Dose dependent manner can be 
clearly observed. 
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Cone. Time (min) Rate (%niin"^) 
1 117.50113.12 0.60±0.07 
2 63.00土 8.29 1.13±0.16 
4 29.75±3.30 2.37±0.26 
6 16.75±1.71 4.21±0.42 
8 13.75±1.71 5.15±0.62 
Table 5.3. Time required for various concentration of Gegen aqueous extract to give 
70% vasodilation. Rate represents 70%/time, that is the percentage relax per minute. 
Data are mean 士 SD of 4 aorta rings each group. 
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Figure 5.6. Linear dose-relaxation relationship between vasodilation rate and Gegen 
aqueous extract concentration. Data are mean 土 SD of 4 aorta rings each group. 
R2=0.9903 implies linear relationship obtained. 
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d) Comparison among the three samples 
The dose response of the three samples, 7:3 (D:G) compound formula, Danshen 
(D) and Gegen (G), was illustrated in the previous part of results individually. The 
effectiveness of them can be compared by combining the graphs in figures 5.2, 5.4 
and 5.6. 
As shown in figure 5.7, within the range of 1 mg/ml to 4 mg/ml, greater slope 
was shown in regression line of 7:3 (D:G) compound formula than that of individual 
Danshen and Gegen. 7:3 (D:G) compound formula showed higher vasodilation rate 
than both individual Danshen and Gegen when the same dose concentration were 
compared. For example, when compare at the dose 3 mg/ml, the rate of vasodilation 
of 7:3 (D:G) compound formula, Danshen and Gegen are 5.3 %min"^ 3.8 %min'' 
and 2.7 %min"^ respectively. The beneficial effect of compound formula of Danshen 
and Gegen was shown in this part of study. 
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Figure 5.7. Comparison of the vasodilation effect among 7:3 (D:G) compound 
formula, Danshen (D) and Gegen (G). For the dose 3 mg/ml, the rate of vasodilation 
of 7:3 (D:G) compound formula, Danshen and Gegen are 5.3 %mm\ 3.8 %min"^ 
and 2.7 %min"^ respectively where the potency were 7:3 (D:G) compound formula, 
Danshen and Gegen in descending order. Data are mean 土 SD of 4 aorta rings each 
group. 
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5.1.3 Discussion 
All the three samples 7:3 (D:G) compound formula, Danshen (D) and Gegen (G) 
gave vasodilation effect to the isolated SD rat aorta rings. The mode of effects of them 
was slow acting and it is very different from other known vasodilating drugs. 
Therefore, the accumulating dose response cannot be studied and the time taken of 
various concentrations to obtain 70% relaxation of single dose was studied instead. 
7:3 (D:G) compound formula and Danshen showed a faster effect than Gegen when 
compared at the same concentration. For long-term cardiovascular tonic supplement, 
slow acting vasodilation effect of the 7:3 (D:G) compound formula is believed to be 
more suitable for patients with cardiovascular disease rather than fast acting drugs. 
As the potency were 7:3 (D:G) compound formula, Danshen and Gegen in 
descending order, it clearly showed the beneficial effect of combing use of Danshen 
and Gegen. For example, when compare at the dose 3 mg/ml, the rate of vasodilation 
of 7:3 (D:G) compound formula, Danshen and Gegen are 5.3 %min"\ 3.8 %min"^ 
and 2.7 %min'^ respectively. In addition, the combine effect was not only in an 
addition of effect from Danshen and Gegen, but in fact the beneficial effect was in a 
multiplied way. It was because 7:3 (D:G) compound formula only extracted from 70% 
Danshen plus 30% Gegen, but its effect is much higher than the sum effect of 70% 
individual Danshen and 30% Gegen when compared in terms of rate of vasodilation 
in the unit of %min"^ The synergistic effect of 7:3 (D:G) compound was observed in 
this part of experiment. 
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5.2 Endothelium dependent vasodilation 
Pharmaceutical agents have different effects on endothelial function. Recently, 
von zur Miihlen and co-workers demonstrated that angiotensin converting enzyme 
(ACE) inhibition improved endothelium dependent vasodilation both in patients with 
untreated hypertension and in normotensive patients (von zur Miihlen et al., 2001). 
They also found that an angiotensin-II subtype-receptor antagonist, irbesartan, and 
Pi-selective adrenoreceptor antagonist, atenolol, improve endothelium dependent 
vasodilation (von zur Muhlen et al, 2001). Statins and other lipid-lowering drugs, 
such as cholestyramine, have been shown to have beneficial effects on endothelium 
dependent vasodilation in hypercholesterolemic patients (Duffy et al. 2001). 
In order to investigate whether the effect of Danshen and Gegen on the 
vasodilation is an endothelium dependent vasodilation, the effect of them were tested 
on aorta without endothelium and aorta pre-treated in nitric oxide synthase inhibitor 
separately. 
5.2.1 Materials and Methods 
Chemicals 
(R)-(-)-phenylephrine hydrochloride (Phe), acetylcholine chloride (Ach), 9,11-
dideoxy-9a, 11 a-epoxymethano prostaglandin (U46619) and N°-nitro-L-arginine 
(L-NNA) were purchased from Sigma. Krebs solution (118.0 mM NaCl, 4.7 mM KCl, 
1.64 mM MgS04，1.2 mM KH2PO4, 5.55 mM D-glucose, 25.0 mM NaHCOs and 2.5 
mM CaCh) was adjusted to pH 7.4 and filtered. 
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Animal 
Aorta was excised from 300 g male Sprague-Dawley (SD) rats and placed in 
Krebs solution. After fat and connective tissue were removed, aorta was cut into 1 
mm width rings. The isolated aorta rings were suspended between two stainless steel 
hooks in organ bath. The condition was maintained at 37°C Krebs solution and was 
gassed with mixture of 95% O2 and 5% CO2. The tension was slowly adjusted 
mechanically up to 1 g with an increasing rate not more then 0.2 g each 5 minute 
intervals. Finally 1 g basal tension was applied to the aorta rings. 
Removal of endothelial layer 
The endothelium was removed by using forceps gently rubbing the intimal 
surface of the aorta on the hand with a clean glove. The glove was pre-moistened with 
Krebs solution before handling the aorta rings. 
Pre-test 
The validity of the aorta rings was confirmed by contraction with 0.3uM 
phenylephrine and then relaxation with 0.3 jiM acetylcholine. If 70% or more 
relaxation was shown when comparing to the 0.3 \lM Phenylephrine induced 
contraction, the aorta ring was defined to be suitable for further use as the endothelial 
layer remained intact for control group. And the aorta fail to give vasodilation 
response to 0.3 |iM acetylcholine confirmed the absence of functional endothelium. 
Aorta ring was then equilibrated for an hour with three times changing Krebs solution 
before the test of samples. 
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Drug test 
The aorta rings were contracted by lOnM U46619, which is a potent 
prostaglandin H2 receptor agonist, for 20 minutes. Samples were then added to the 
organ bath and the vasomotion were monitored throughout the experiment. Samples 
were prepared by Krebs solution. For the nitric oxide synthase inhibitory group, 100 
|iM L-NNA was added and incubated for 30 minutes before adding U46619. 
Measurement 
Tensions were recorded by MacLab data acquisition system through Grass 
force-displacement transducers, FT-03E. Data was recorded by a sampling rate of 10 
per second. The background noise of raw data was then removed by triangular 
(Bartlett) window type of smoothing with window size of 201 points width before 
analysis. Finally, results were expressed as percentage relaxation response of the 
maximal contraction induced by 10 nM U46619. 
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5.2.2 Results 
Removal of endothelial layer 
a) Danshen 
No significant difference between the vasodilation of normal group with 
endothelium and the test group without endothelium under the treatment of 4 mg/ml 
Danshen was observed as shown in figure 5.8. The effect on the removal of functional 
endothelium could be observed in figure 5.8 that no relaxation was observed after 
addition of acetylcholine in the pre-test. After calculation, the results were expressed 
as percentage relaxation response of the maximal contraction induced by 10 nM 
U46619. The percentage relaxation against the time course was plotted as figure 5.9. 
Only 2 time points, namely and minute, showed significant differences while 
no significant differences between the two groups with and without endothelium at all 
other time points were observed. Therefore, the vasodilation effect of Danshen is not 
due to the presence of endothelium. 
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Figure 5.8. Screenshot of the MacLab system showing the vasodilation of the 
Danshen aqueous extract in the presence and the absence of endothelium. Vertical 
dimension represents the tension force of the aorta ring in the unit of gram (g) and the 
horizontal dimension represents the time course during the experiment. Channel 1 and 
2 are normal aorta rings with intact endothelium while channel 3 and 4 are 
endothelium removed. The removal of functional endothelium could be observed in 
channel 3 and 4 that no relaxation was observed after addition of acetylcholine in the 
pre-test. Concentration of Danshen added to all channels was 4 mg/ml. No differences 
could be observed between 2 groups. 
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Figure 5.9. Endothelium independent vasodilation of Danshen aqueous extract. (wE) 
represents with endothelium, (woE) represents without endothelium. Data are mean 土 
SD of 4 aorta rings of each group. *P<0.05, compares with relaxation of the 
endothelium removed group. 
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b) Gegen 
There are significant differences between the vasodilation of normal group with 
endothelium and the test group without endothelium under the treatment of 4 mg/ml 
Gegen extract was observed as shown in figure 5.10. The Group without endothelium 
did not show the vasodilation effect of Gegen extract after Gegen treatment. The 
effect of removal of endothelium could be observed in figure 5.10 that no relaxation 
was observed after addition of acetylcholine in the pre-test. After calculation, the 
results were expressed as percentage relaxation response of the maximal contraction 
induced by 10 nM U46619. The percentage relaxation against the time course was 
plotted and shown in Figure 5.11. Only 2 time points, namely and 3��minu te , 
showed no significant differences while there were significant differences between 
groups with and without endothelium at all other time points. Therefore the 
vasodilation effect of Gegen is mediated by the presence of endothelium. 
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Figure 5.10. Screenshot of the MacLab system showing the vasodilation of the Gegen 
aqueous extract in the presence and the absence of endothelium. Vertical dimension 
represents the tension force of the aorta ring in the unit of gram (g) and the horizontal 
dimension represents the time course during the experiment. Channel 1 and 2 are 
normal aorta rings with intact endothelium while channel 3 and 4 are endothelium 
removed. The removal of functional endothelium could be observed in channel 3 and 
4 that no relaxation was observed after addition of acetylcholine in the pre-test. 
Concentration of Gegen added to all channels was 4 mg/ml. Vasodilation effect was 
impaired in the endothelium removed group. 
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Figure 5.11. Endothelium dependent vasodilation of Gegen aqueous extract. (wE) 
represents with endothelium, (woE) represents without endothelium. Data are mean 土 
SD of 4 aorta rings of each group. *P<0.05, compares with relaxation of the 
endothelium removed group. 
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Nitric oxide synthase inhibitor, L-NNA 
a) Danshen 
No significant different in the vasodilation was observed between the normal 
group without nitric oxide synthase inhibitor and the test group with inhibitor, L-NNA, 
under the treatment of 4 mg/ml Danshen as shown in figure 5.12. The effect of 
addition of 100 |liM L-NNA could be observed in figure 5.12 that 30 minutes 
incubation before the U46619 induced vasoconstriction. After calculation, the results 
were expressed as percentage relaxation response of the maximal contraction induced 
by 10 nM U46619. The percentage relaxation against the time was plotted and shown 
in figure 5.13. Only 2 time points, namely and 11^ minute, showed significant 
differences while no significant differences between with and without inhibitor groups 
at all other time points was observed. Therefore the vasodilation effect of Danshen is 
not due to the production of nitric oxide nitric by oxide synthase. 
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Figure 5.12. Screenshot of the MacLab system showing the vasodilation of the 
Danshen aqueous extract in the presence and absence of 100 |iM L-NNA. Vertical 
dimension represents the tension force of the aorta ring in the unit of gram (g) and the 
horizontal dimension represents the time course during the experiment. Channel 1 and 
2 are normal aorta rings without L-NNA while channel 3 and 4 are pre-treated with 
L-NNA for 30 minutes before test. Concentration of Danshen added to all channels 
was 4 mg/ml. No differences could be observed between 2 groups. 
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Figure 5.13. Nitric oxide synthase independent vasodilation of Danshen aqueous 
extract. Danshen (L-NNA) represents presence of 100 jiM L-NNA, Danshen 
represents the absence of L-NNA. Data are mean 士 SD of 4 aorta rings of each group. 
*P-value<0.05, compares with relaxation of the endothelium removed group. 
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b) Gegen 
There are significant differences between the vasodilation in the normal group 
without nitric oxide synthase inhibitor and the test group with inhibitor, L-NNA, with 
the treatment of 4 mg/ml Gegen extract as shown in figure 5.14. The Group with 
nitric synthase inhibitor, 100 i^M L-NNA, impaired the vasodilation effect of Gegen 
extract. The effect of addition of 100 |iM L-NNA could be observed in figure 5.14 
that 30 minutes incubated before the U46619 induced vasoconstriction. After 
calculation, the results were expressed as percentage relaxation response of the 
maximal contraction induced by 10 nM U46619. The percentage relaxation against 
the time was plotted and shown in figure 5.15. Only 2 time points, namely and 
minute, showed no significant differences while there are significant differences 
found in the groups with and without inhibitor at all other time points. Therefore, the 
vasodilation effect of Gegen is due to the production of nitric oxide by nitric oxide 
synthase. 
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Figure 5.14. Screenshot of the MacLab system showing the vasodilation of the Gegen 
aqueous extract in the presence and absence of 100 |iM L-NNA. Vertical dimension 
represents the tension force of the aorta ring in the unit of gram (g) and the horizontal 
dimension represents the time course during the experiment. Channel 1 and 2 are 
normal aorta rings without L-NNA while channel 3 and 4 are pre-treated with L-NNA 
30 minutes before test. Concentration of Gegen added to all channels was 4 mg/ml. 
Vasodilation effect was impaired in the nitric oxide synthase group. 
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Figure 5.15. Nitric oxide synthase dependent vasodilation of Gegen aqueous extract. 
Gegen (L-NNA) represents presence of 100 )iM L-NNA, Gegen represents the 
absence of L-NNA. Data are mean 土 SD of 4 aorta rings of each group. *�<0.05, 
compares with relaxation of the endothelium removed group. 
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5.2.3 Discussion 
Gegen aqueous extract exhibited endothelium dependent vasodilation as the 
removal of endothelial layer impaired the Gegen vasodilation effect. The finding that 
pre-treatment of nitric oxide synthase inhibitor also impaired the effect of Gegen 
aqueous confirmed that the vasodilation of Gegen are thought the up regulation of 
nitric oxide production by nitric oxide synthase. As many cardiovascular diseases are 
associated with an impairment of endothelium-dependent vasodilation, the finding 
that Gegen aqueous extract can stimulate the endothelium dependent vasodilation 
implied its beneficial effect to the cardiovascular diseases. In addition, nitric oxide 
was also found to have anti-platelet effect (Benjamin et al., 1991 ； Moro et al., 1996) 
and anti-adhesive effect (Kubes et al., 1991), that is why Gegen was used to treat 
coronary heart disease and vascular diseases traditionally. 
For the Danshen aqueous extract, result shows that the vasodilation effect of 
Danshen was an endothelium independent response. The possibility of the 
involvement of nitric oxide synthase can be excluded for Danshen. 
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Chapter 6 Anti-platelet study 
People are very concerned platelet aggregation and thrombosis in cardiovascular 
diseases. They lead to deterioration of the blood vessels and complicated with 
atherosclerosis, myocardial infarction, stroke etc. Anti-platelet is a large topic in 
dealing with cardiovascular diseases. 
Anti-platelet aggregation effects of Danshen and Gegen have been studied for a 
long time. A compound known as 2-isopropyl-8-methylphenanthrene-3,4-dione was 
isolated from Danshen which showed 30 times more potent than papaverine in 
anti-platelet aggregation when their IC50 were compared (Onitsuka et al., 1983). 
Related diketophenanthrene derivatives such as tanshinone I, tanshinone II and 
cryptotanshinone were also found to have the inhibitory activity with less potency. 
Puerarin was isolated from Gegen which can elevate PGI2 level. An increase in PGI2 
level results in an inhibition of platelet aggregation and improves blood flow (Yang et 
al.’ 1990). 
Apart from the anti-platelet aggregation effect, the effect of the 7:3 (D.G) 
compound formula on long-term platelet formation was unclear and was investigated 
in this study. The first model applied was colony-forming-unit megakaryocyte 
(CFU-MK) plasma clot colony assay. 
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6.1 CFU-MK plasma clot colony assay 
Megakaryocyte (MK) is the progenitor cell of blood platelet. The bone marrow 
stem cells are capable to differentiate into different cell types under different 
cytokines stimulation during hematopoiesis. Thrombopoietin (TPO) is the key 
cytokine to stimulate the differentiation of MK cells and the formation of platelets. 
Therefore, CFU-MK plasma clot colony assay was applied to investigate the 
anti-platelet formation effect of 7:3 (D:G) compound formula, Danshen (D) and 
Gegen (G) aqueous extract. 
6.2 Materials and Methods 
Chemicals 
Iscove's modified Dulbecco's medium (IMDM) was purchased from Life 
Technologies (Gibcobrl). Cytokines of recombinant Human IL-3 and thrombopoietin 
(TPO) were purchased from PeproTech. Fetal calf serum (FCS), 2-mercaptoethanol 
(2mE), bovine serum albumin (BSA), bovine plasma and calcium chloride (CaCy 
were purchased from Sigma. Acetylcholine esterase (AChE) staining solution was 
made up of 0.5 mg/ml acetylthiocholine iodide, 100 mM sodium citrate, 3 mM 
cuppric sulfate, 0.5 mM potassium ferricyanate in 0.1 M PBS, pH 6.0. 
Animal 
Female six to eight weeks old BALB/C mice were killed by cervical dislocation. 
Femurs were removed and cut at both ends. Bone marrow was expelled with 2 ml 
IMDM by inserting 21- to 23-gauge needle into the end of femurs. Bone marrow cells 
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were dispersed and washed twice with IMDM by centrifUgation at 300 x g for 10 
minutes. 
Plasma clot system 
Bone marrow cells were cultured in 35 mm petri dishes using the plasma clot 
culture method. 2 x 10^  cells were cultured in 1 ml system of IMDM with 10% FCS, 
lo/o BSA，10-^  M 2mE，0.34 mg/ml CaCb, 10% bovine plasma, 20 ng/ml IL-3, 50 
ng/ml TPO and various concentrations of samples. Dishes were incubated at 37 in 
a fully humidified atmosphere with 5% CO2 for 7 days. 
Acetylcholine esterase staining 
The culture plates were fixed with 1 % paraformaldehyde in phosphate buffer 
(pH 6.0) for 15 minutes and dehydrated in the petri dishes. The fixed plates were then 
washed in phosphate buffer (pH 6.0). And then covered with acetylcholinesterase 
(AChE) staining solution for 4 hours at room temperature for identification of 
megakaryocyte colonies. Inverted microscopy was used for scoring the 
megakaryocyte colonies. A megakaryocyte colony was defined as a cluster of 3 or 
more AChE-positive cells as show in figure 6.1. 
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• 
Figure 6.1. Two megakaryocyte colonies observed under inverted microscope. Where 
magnification is 400X. 
- 9 9 -
Cardiovascular Tonic Effects of Danshen and Gegen 
6.3 Results 
All of the three samples, namely 7:3 (D:G) compound formula, Danshen and 
Gegen aqueous extracts show inhibition to the MK cell proliferation. The MK 
colonies counts were shown in Figure 6.2 as a bar chart. The numbers of colonies of 
all three groups were found to drop gradually when the concentration increased from 
50 |ig/ml to 1000 |ig/ml. IC50 was applied to compare their potency on the inhibition 
of MK cell proliferation (Figure 6.3). IC50 of Danshen, Gegen and 7:3 (D:G) formula 
were found to be 52 ^ig/ml, 97|ig/ml and 161 |ig/ml in a descending order 
respectively. 
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Figure 6.2. The number of MK colonies counts after 7 days incubation with 7:3 (D:G) 
compound formula, Danshen and Gegen in various concentrations. Data were 
presented by mean 土 SD of 5 dishes each group. *P-value < 0.05 against control. 
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Figure 6.3. The IC50 of MK colonies inhibition by 7:3 (D:G) compound formula, 
Danshen and Gegen. IC50 of Danshen, Gegen and 7:3 (D:G) formula were found to 
be 52 |ig/ml, 97 fig/ml and 161 |ig/ml in descending order respectively. Data were 
presented by mean 土 SD of 5 dishes each group. 
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6.4 Discussion 
The inhibitory effect of 7:3 (D:G) formula, Danshen and Gegen on the 
megakaryocyte proliferation under the stimulation of TPO and IL-3 were 
demonstrated. As the MK cell proliferation was inhibited, the amount of platelets 
production would also be reduced. It is beneficial to the cardiovascular disease 
patients which they take these herbal products. The IC50 of Danshen was found to be 
the smallest among the three samples tested. This implies that the effect of the 7:3 
(D:G) compound formula is largely contributed by effects of Danshen. 
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Chapter 7 Discussions and prospects 
7.1 Discussions 
The following findings were observed throughout my study: 
a) The 7:3 (D:G) compound formula demonstrated antioxidative effect against 
AAPH induced RBC hemolysis with IC50 of 168 ^ig/ml. 
b) The 7:3 (D:G) compound formula protected ex-vivo ischemia reperfusion heart to 
have 60% contractile force recovery and reduced the heart damage which was 
reflected by tissue specific enzyme LDH and CK assays. 
c) The 7:3 (D:G) compound formula caused vasodilation to the pre-contracted 
ex-vivo aorta and synergistic effect of compound formula was shown. 
d) Danshen extract showed endothelium independent vasodilation, while the 
vasodilation effect of Gegen extract was found to be endothelium dependent and 
the mechanism is via the function of nitric oxide synthase. 
e) The 7:3 (D:G) compound formula inhibited MK cell proliferation at IC50 of 161 
昭/ml. 
The above-mentioned findings in our study imply that 7:3 (D:G) compound formula 
is beneficial to cardiovascular disease patients as it showed antioxidative effects， 
vasodilation effect and anti-platelet formation effect. 
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The cardiovascular tonic effect of 7:3 (D:G) compound formula was 
demonstrated in three areas of antioxidant, vasodilation and anti-platelet formation. 
However, the antioxidative effect is mainly due to Danshen. Antioxidant quenches the 
oxidative reactive species in the blood stream which lower the chance of oxidizing 
LDL formation. It would reduce the chance of atherosclerosis formation and its other 
complicated adverse effects. Danshen and Gegen exert vasodilation via endothelium 
independent and dependent mechanism respectively. Endothelium dependent 
vasodilation increased endogenous nitric oxide to the smooth muscle cells. Lower 
blood pressure would not only reduce the chance of development of stroke and 
myocardial infarction, but also reduce morbidity and mortality of cardiovascular 
diseases. Danshen and Gegen are demonstrated to have different effects on different 
areas studied by us in this thesis. It supports that herbal practitioners view people as 
ecosystem in miniature and use compound formula to improve one's capacity to 
balance and renew his resources. The different TCM components in the compound 
formula affect different organs to give the final outcome of body resources balanced. 
For the compound formula research, 7:3 (D:G) compound formula shows 
enhanced extraction efficiency of Salvianolic acid B when comparing to individual 
Danshen (as mentioned in chapter 3). Therefore each component TCM of a compound 
formula may play a very important role in affecting the extraction efficiency on each 
other component TCM. It further supports the validity of our methodology that the 
compound formulae were prepared by mixed TCMs decoction but not mixing extract 
of individual TCM. It is a more precise method to study the compound formulae of 
Chinese Medicines as TCMs are always decocted by a mixture of herbs. Further 
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experiments should be done on comparing the chemical species of the compound 
formulae with individual TCMs. In order to investigate the additive effect of TCMs, 
the TCMs should be used in compound formula to enhance or neutralize another 
component TCM. 
In the figure 5.7 in chapter 5, it showed the synergistic effect of combined use of 
Danshen and Gegen. The benefit of the 7:3 (D:G) compound formula has been 
definitely confirmed although the underlying mechanism is still unknown. These 
findings and methodologies are not only valuable for the further study of the 
Danshen-Gegen compound formula, but also useful for other TCM compound 
formula studies in which combined formula with different herbal materials may be 
included. 
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7.2 Prospects 
7.2.1 The 7:3 (D:G) compound formula capsule with GMP 
The 7:3 (D:G) compound formula capsules as shown in figure 7.1, 500 mg 
extract encapsulated each, were manufactured with compliance to GMP by Hong 
Kong Institution of Biotechnology (HKIB). It is a very good milestone to make TCM 
to be accepted in Western countries. GMP is a part of quality assurance which ensures 
that products are consistently produced and controlled to the quality standards 
appropriate to their intended use and as required by the marketing authorization. Raw 
material should be harvested at the best birthplace and period, and should be 
authenticated to contain no adulterants and substitutes. They are ensured to be free of 
heavy metals, remaining pesticides and micro-organisms. The materials should be 
examined by visual and chemical parameters. The amount of active ingredients should 
be monitored by bioassays. 
As GMP was the international recognitions and guaranteed the quality, it is 
pivotal to the international market. In addition, TCM in capsule form brings benefits 
to users to reduce the amount of intake and save time for decoction. 
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國 
Figure 7.1. The 7:3 (D:G) compound formula capsules manufactured by HKIB. 
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7.2.2 Clinical trial of the capsule 
The approval of Clinical Research Ethical Committee on the issue of performing 
clinical trial of Danshen to Gegen in 7:3 ratio compound formula was obtained. 
Double blind test with placebo method was employed. The clinical trial was started in 
May 2002 at Prince of Wales Hospital, Hong Kong. Secondary prevention was 
studied first where all participants have cardiovascular disease records that at least 
one vessel shows 50% atherosclerosis. Participants have to intake 6 capsules daily 
(manufactured in compliance of GMP, see section 7.2.1), 3 in the morning and 3 in 
the night, for a 24-weeks period and their cases were monitored once a week. The 
clinical trial is still in progress. 
-109 -
Cardiovascular Tonic Effects of Danshen and Gegen 
References 
Benjamin N.，Dutton J.A.E. and RitterJ.M. (1991). Human vascular smooth muscle 
cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence 
for generation of nitric oxide. Br J Pharmacol. 102，847 - 850. 
Buda C., Sallanon M. and Jin G.Z. (1984). Effect of 1-tetrahydropalmatine on 
sleep-waking cycle of cats. Zhongguo Yao Li Xue Bao. 5, 5-8. 
Chai X.S.，Wang Z.X., Chen P.P., Wang L.Y., Lu X.R. and Kang B. (1985). 
[Anti-arrhythmic action of puerarin]. Zhongguo Yao Li Xue Bao. 6，166-8. 
Cochrane C.G. (1991). Mechanisms of oxidant injury of cells. Mol Aspects Med. 12, 
137-47. 
Duffy S.J., O'Brien R.C.，New G., Harper R.W. and Meredith I.T. (2001). Effect of 
anti-oxidant treatment and cholesterol lowering on resting arterial tone, metabolic 
vasodilation and endothelial function in the human forearm: a randomized, 
placebo-controlled study. Clin Exp Pharmacol Physiol. 28, 409-18. 
Fan L丄.，Zeng G.Y.，Zhou Y.R, Zhang L.Y. and Cheng Y.S. (1982). Pharmacologic 
studies on Radix puerariae: effects of puerariae flavones on coronary circulation, 
cardiac hemodynamics and myocardial metabolism in dogs. Chin Med J (Engl). 
95, 145-50. 
Fan S., Sun L.，Wu Y.，Zhao H. and Zhang F. (1997). [Effects of both puerarin and 
gypsum on the firing of pyrogen-treated thermosensitive neurons in the region 
POAH of anesthetized cats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 13, 
71-4. 
Feng Y.R, Zhang L.Y. and Zeng G.Y. (1984). [Effect of puerarin and analogues of 
daidzein on adrenoceptors]. Zhongguo Yao Li Xue Bao. 5, 238-41. 
Furchgott R.F. and Zawadzki J.V. (1980). The obligatory role of endothelial cells in the 
relaxation of arterial smooth muscle by acetylcholine. Nature. 288, 373 - 376. 
Halliwell B. (1997). Antioxidants and human disease: a general introduction. Nutr 
Rev. 55，44-52. 
Hearse DJ. (1994). Myocardial ischaemia: can we agree on a definition for the 21st 
century? Cardiovasc Res. 28, 1737-44. 
Ho C.T. and Zheng Q.Y. (2002). Quality management of nutraceuticals. Washington, 
DC: American Chemical Society. 
-110 -
Cardiovascular Tonic Effects of Danshen and Gegen 
Hu J., Xie J.，Hu J., Zhang Y.，Wang J. and Chen R. (1994). [Effect of some drugs on 
electroacupuncture analgesia and cytosolic free Ca2+ concentration of mice 
brain]. Zhen Ci Yan Jiu. 19, 55-8. 
Huang P.L., Huang Z.，Mashimo H.，Bloch K.D., Moskowitz M.A., Bevan J.A. and 
Fishman M.C. (1995). Hypertension in mice lacking the gene for endothelial 
nitric oxide synthase. Nature. 377，239 - 242. 
Huang T.K. and Shi C. (1996). Zhong yao fang ji xian dai yan jiu da dian. Beijing: Ke 
xue chu ban she. 
Ji X.，Tan B.K., Zhu Y.C., Linz W. and Zhu Y.Z. (2003). Comparison of 
cardioprotective effects using ramipril and DanShen for the treatment of acute 
myocardial infarction in rats. Life Sci. 73, 1413-26. 
Jin G.Z.，Xu J., Zhang F.T., Yu L.P.，Li J.H. and Wang X丄.（1983). [Relevance of the 
sedative-tranquilizing effect of 1-tetrahydropalmatine to brain monoaminergic 
neurotransmitters]. Zhongguo Yao Li Xue Bao. 4, 4-10. 
Kang D.G., Yun Y.G., Ryoo J.H. and Lee H.S. (2002). Anti-hypertensive effect of 
water extract of danshen on renovascular hypertension through inhibition of the 
renin angiotensin system. Am J Chin Med. 30, 87-93. 
Kannel W.B. (2000). Fifty years of Framingham Study contributions to understanding 
hypertension. J Hum Hypertens. 14, 83 - 90. 
Keung W.M. and Vallee B丄.(1998). Kudzu root: an ancient Chinese source of modem 
antidipsotropic agents. Phytochemistry. 47，499-506. 
Kubes P., Suzuki M. and Granger D.N. (1991). Nitric oxide: An endogenous 
modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 88，4651 - 4655. 
Luscher T.F. and Noll G. (1995). The pathogenesis of cardiovascular disease: role of 
the endothelium as a target and mediator. Atherosclerosis. 118, 81-90. 
Manning A., Bemier M., Crome R., Little S. and Hearse D. (1988). 
Reperfiision-induced arrhythmias: a study of the role of xanthine oxidase-derived 
free radicals in the rat heart. J Mol Cell Cardiol. 20, 35-45. 
McCord J.M., Roy R.S. and Schaffer S.W. (1985). Free radicals and myocardial 
ischemia. The role of xanthine oxidase. Ady Myocardiol. 5, 183-9. 
Moncada S. and Higgs A. (1993). Mechanisms of disease: the L-arginine - nitric oxide 
pathway. New Engl J Med. 329, 2002 - 2012. 
Moncada S.，Palmer R.M. and Higgs E.A. (1991). Nitric oxide: physiology, 
pathophysiology, and pharmacology. Pharmacol Rev. 43，109-42. 
- I l l -
Cardiovascular Tonic Effects of Danshen and Gegen 
Moro M.A., Russel R.J., Cellek S., Lizasoain L, Su Y.，Darley-Usmar V.M., Radomski 
M.W. and Moncada S. (1996). cGMP mediates the vascular and platelet actions of 
nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc 
Natl Acad Sci USA. 93, 1480-1485. 
Onitsuka M., Fujiu M., Shinma N.，Maruyama H.B. (1983). New platelet aggregation 
inhibitors from Tan-Shen; radix of Salvia miltiorrhiza Bimge. Chem. Pharm. Bull. 
31，1670-5. 
Palmer R.M., Ferrige A.G. and Moncada S. (1987). Nitric oxide release accounts for 
the biological activity of endothelium-derived relaxing factor. Nature. 327, 524-6. 
Radomski M.W. and Moncada S.(1993). Regulation of vascular homeostasis by nitric 
oxide. Thromb Haemost. 70，36-41. 
Rossi G.R, Seccia T.M. and Nussdorfer G.G. (2001). Reciprocal regulation of 
endothelin-1 and nitric oxide: relevance in the physiology and pathology of the 
cardiovascular system. Int Rev Cytol. 209, 241 - 272. 
Rubanyi G.M., Romero J.C. and Vanhoutte P.M. (1986). Flow-induced release of 
endothelium-derived relaxing factor. Am J Physiol. 250，1145-9. 
Ryu S.Y., Lee C.O. and Choi S.U. (1997). In vitro cytotoxicity of tanshinones from 
Salvia miltiorrhiza. Planta Med. 63, 339-42. 
Soji Y., Kadokawa T., Masuda Y.，Kawashima K. and Nakamura K. (1969). [Effects of 
Corydalis alkaloid upon inhibition of gastric juice secretion and prevention of 
gastric ulcer in experimental animals]. Nippon Yakurigaku Zasshi. 65, 196-209. 
Song X.P., Chen P.P. and Chai X.S. (1988). [Effects of puerarin on blood pressure and 
plasma renin activity in spontaneously hypertensive rats]. Zhongguo Yao Li Xue 
Bao. 9, 55-8. 
Spence J.D. (1984). Hemodynamic effects of antihypertensive drugs. Possible 
implications for the prevention of atherosclerosis. Hypertension. 6，163-8. 
Spence J.D.，Perkins D.G.，Kline R丄•，Adams M.A. and Haust M.D. (1984). 
Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs 
hydralazine in hypertensive hyperlipidemic rabbits. Atherosclerosis. 50, 325-33. 
Stamler J.S., Loh E.，Roddy M.A” Currie K.E.and Creager M.A. (1994). Nitric oxide 
regulates basal systemic and pulmonary vascular resistance in healthy humans. 
Circulation. 89, 2035 - 2040. 
Suematsu M., Schmid-Schonbein G.W., Chavez-Chavez R.H., Yee T.T., Tamatani T., 
Miyasaka M., Delano F.A. and Zweifach B.W. (1993). In vivo visualization of 
oxidative changes in micro vessels during neutrophil activation. Am J Physiol. 
264,881-91. 
-112 -
Cardiovascular Tonic Effects of Danshen and Gegen 
Tseng K.Y., Chou Y.P., Chang L.Y. and Fang L.L. (1974). [Pharmacologic studies of 
Radix puerariae. I. Its effect on dog arterial pressure, vascular reactivity, and 
cerebral and peripheral circulation]. Zhonghua Yi Xue Za Zhi. 5, 265-70. 
von zur Muhlen B., Kahan T., Hagg A., Millgard J. and Lind L. (2001). Treatment 
with irbesartan or atenolol improves endothelial function in essential 
hypertension. J Hypertens. 19, 1813-8. 
von zur Muhlen B.，Millgard J. and Lind L.(2001). Divergent effects of different 
beta-blocking agents on endothelium-dependent vasodilatation in the human 
forearm. Blood Press. 9, 287-92. 
Wang B.S., Wang L.J., Zhang Y.B.，Lu J.S., Tang N.，Huang Y.T., Yan W.H. and Song 
W. (1997). Reduction of myocardial ischemia-reperfiision injury by isovolumic 
hemodilution. Clin Hemorheol Microcirc. 17，181-6. 
Ward PA. (1991). Mechanisms of endothelial cell injury. J Lab Clin Med. 118, 421-6. 
Wu YJ., Hong C.Y., Lin S.J., Wu P. and Shiao M.S. (1998). Increase of vitamin E 
content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a 
water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler 
Thromb Vase Biol. 18, 481-6. 
Xue Q.F. (1986). [Effect of ligustrazine and salvia miltiorrhiza on microcirculation in 
the hamster cheek pouch]. Zhonghua Yi Xue Za Zhi. 66，334-7. 
Yang G.，Zhang L. and Fan L. (1990). [Anti-angina effect of puerarin and its effect on 
plasma thromboxane A2 and prostacyclin]. Zhong Xi Yi Jie He Za Zhi. 10, 82-4. 
Yue K丄.（1981) [Analgesic and antispastic effects of protopine]. Zhongguo Yao Li 
Xue Bao. 2, 16-8. 
Zhong R.X., Shi R.R., Huang L.X. Liu H. Tao J.Y. and Zhu X.Y. (1986). Spasmolytic 
effect of protopine and Corydalis decumbens on isolated cat ciliary muscle and 
















































































































































































































































































































































































































CUHK L i b r a r i e s 
_圓 _ 1丨 1 
QDMQ7f l37M 
